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Abstract 
Electrochemical detection methods are highly attractive for the monitoring of glucose, 
cholesterol, cancer, infectious diseases, and biological warfare agents due to their low cost, high 
sensitivity, functionality despite sample turbidity, easy miniaturization via microfabrication, low 
power requirements, and a relatively simple control infrastructure. The development of 
implantable biosensors is laden with great challenges, which include longevity and inherent 
biocompatibility, coupled with the continuous monitoring of analytes. Deficiencies in any of 
these areas will necessitate their surgical replacement. In addition, random signals arising from 
non-specific adsorption events can cause problems in diagnostic assays. Hence, a great deal of 
effort has been devoted to the specific control of surface structures. Nanotechnology involves the 
creation and design of structures with at least one dimension that is below 100 nm. The optical, 
magnetic, and electrical properties of nanostructures may be manipulated by altering their size, 
shape, and composition. These attributes may facilitate improvements in biocompatibility, 
sensitivity and the specific attachment of biomaterials. Thus, the central theme of this 
dissertation pertains to highlighting the critical roles that are played by the morphology and 
intrinsic properties of nanomaterials when they are applied in the development of 
electrochemical biosensors. 
For this PhD project, we initially designed and fabricated a novel amperometric glucose 
biosensor based on the immobilization of glucose oxidase (GOx) on a Prussian blue modified 
nanoporous gold surface, which exhibited a rapid response and a low detection limit of 2.5 μM 
glucose. The sensitivity of the biosensor was found to be very high (177 μA/mM) and the 
apparent Michaelis–Menten constant was calculated to be 2.1 mM. Our study has demonstrated 
that nanoporous gold provides an excellent matrix for enzyme immobilization. To adopt these 
advanced properties, we fabricated a highly sensitive and mediator-free electrochemical 
biosensor for the determination of total cholesterol. The developed biosensor possessed high 
selectivity and sensitivity (29.33 μA mM−1 cm−2). The apparent Michaelis–Menten constant, 
of this biosensor was very low (0.64 mM), which originated from both the effective 
immobilization process and the nanoporous structure of the substrate. The biosensor exhibited a 
wide linear range, up to 300 mg dL−1, in a physiological environment (pH 7.4); making it a 
promising candidate for the clinical determination of cholesterol. The fabricated biosensor was 
tested further by utilizing actual food samples (e.g., margarine, butter and fish oil). The results 
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indicated that it has the potential capacity to be employed as a facile cholesterol detection tool in 
the food industry and for supplement quality control. To enhance the stability of the biosensors 
in the continuous monitoring of glucose, we designed a novel platform that was based on 
buckypaper. The fabricated biosensor responded to glucose with a considerable functional 
lifetime of over 80 days and detected glucose with a dynamic linear range of over 9 mM with a 
detection limit of 0.01 mM.  
To investigate the effects of the physical dimensions of nanomaterials on electrochemical 
biosensing, we synthesized TiO2 nanowires with controllable dimensions via a facile thermal 
oxidation treatment of a Ti substrate. To improve the conductivity of the TiO2 nanowires and to 
facilitate the immobilization of enzymes, a thin layer of carbon was deposited onto the TiO2 
nanowires via a chemical vapour deposition method. Upon the immobilization of glucose 
oxidase as a model protein, direct electron transfer was observed in a mediator-free biosensing 
environment. Our electrochemical studies have revealed that the electron transfer rate of the 
immobilized glucose oxidase is strongly dependent on the dimensions of the carbonized TiO2 
nanowires, and that the designed glucose biosensor exhibits a wide linear range, up to 18 mM 
glucose, as well as high sensitivity and selectivity. Glucose measurements of human serum using 
the developed biosensor showed excellent agreement with the data recorded by a commercial 
blood glucose monitoring assay.  
Finally, we fabricated an enzyme-free glucose sensor based on nanoporous palladium-
cadmium (PdCd) networks. A hydrothermal method was applied in the synthesis of PdCd 
nanomaterials. The effect of the composition of the PdCd nanomaterials on the performance of 
the electrode was investigated by cyclic voltammetry (CV). Amperometric studies showed that 
the nanoporous PdCd electrode was responsive to the direct oxidation of glucose with high 
electrocatalytic activity. The sensitivity of the sensor for continuous glucose monitoring was 
146.21 µAmM−1cm−2, with linearity up to 10 mM and a detection limit of 0.05 mM. 
In summary, the electrochemical biosensors proposed in my PhD study exhibited high 
sensitivity and selectivity for the continuous monitoring of analytes in the presence of common 
interference species. Our results have shown that the performance of the biosensors is 
significantly dependent on the dimensions and morphologies of nanostructured materials. The 
unique nanomaterials-based platforms proposed in this dissertation open the door to the design 
and fabrication of high-performance electrochemical biosensors for medical diagnostics. 
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Chapter 1 
Introduction 
Over the past few decades, a number of reports have highlighted the growing importance 
of electrochemical biosensing devices in both clinical and environmental analysis. This may not 
seem as surprising when one considers that electrochemical transduction processes have inherent 
advantages such as low cost; high sensitivity; independence from solution turbidity; simple 
miniaturization that is well-suited to microfabrication; low power requirements; and relatively 
straightforward associated instrumentation. These characteristics make electrochemical sensing 
methods highly attractive in myriad applications, including the detection of cancer, infectious 
diseases, glucose and cholesterol, and biological warfare agents, to name but a few.  
1.1. Nanoscience development 
Nanoscale molecular electrochemistry has followed a line of evolution that had its 
beginnings in the late 1970s via a new intimate interaction between electrochemistry on one side 
and both solid state physics and physical surface science on the other.1 In the midst of this 
evolution, which was almost likened to a renaissance in electrochemical science, single-crystal 
electrodes with well-defined surface structures were, for example, introduced as a major 
breakthrough.1-2 This laid the foundation for subsequent novel electrochemical technologies, not 
the least of which was scanning probe microscopy. At the same time a range of surface science 
techniques and theories were introduced and developed. These included spectroscopy (UV/vis, 
IR, Raman, and X-ray photoelectron spectroscopy (XPS); the development of the quartz crystal 
microbalance and other physical techniques; as well as both statistical mechanical and electronic 
structural theories and computations, all of which were warranted via the new electrochemistry. 
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Shortly afterward, with the onset of scanning probe techniques, STM, and atomic force 
microscopy (AFM), a dramatic enhancement of both the fields of surface science and interfacial 
electrochemistry enabled the capacity for unprecedented levels of elucidation. The atomic 
resolution of pure metals and semiconductor electrode surfaces, and at least the sub-molecular 
resolution of electrochemical adsorbates could now be achieved; opening new worlds through 
the visualization of micro/nanoscopic structures and processes, and novel approaches in 
electrochemical nanotechnologies.3  
As nanotechnology research involves the design and creation of structures with at least one 
dimension that is below 100 nm, researchers may now routinely manipulate the optical, 
magnetic, and electrical properties of materials by altering nanostructured attributes such as size, 
morphology, and atomic composition. The capacity for the synthesis of nanomaterials has 
undoubtedly been a core enabler, since they exhibit unique properties, which have widespread 
applications encompassing electrochemistry, electrocatalysis, optics, electronics, analytical 
devices, energy devices, and so forth. For instance, quantum dots can exhibit green to red 
emission upon dimensional tuning, which is in turn related to changes in quantum confinement.4 
Regarding shape effects, gold nanorods and gold nanocages have strong near-infrared surface 
plasmon resonance (SPR) absorption, whereas Au nanoparticles exhibit only size-dependent 
visible SPR absorption.5 Altering the composition of nanomaterials through the alloying of two 
types of semiconductors may produce new materials that display properties that are distinct not 
only from the properties of their bulk counterparts, but also from those of their parent 
semiconductors.6 For the sensing of small molecules, carbon nanotubes/Au nanoparticle hybrids 
possess a higher electrochemical performance than that of the individual nanomaterials.7 The 
aforementioned adjustments and characterizations may further affect the biocompatibility, 
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sensitivity and specific attachment of biomaterials in the construction of nanometric biosensing 
devices. 
1.2. Electrochemical biosensors 
A typical catalytic biosensor consists of an enzyme layer that is interfaced with a signal 
transducing device. There have been substantial research efforts devoted to the development of 
strategies for incorporating whole cells, components of cells, or subcellular elements from living 
microorganisms, animal and plant tissues into biosensors.  
Insofar as the development of electrochemical biosensors, the facilitation of electron 
transfer between enzymes and electrodes constitutes a tremendous challenge due to the deeply 
embedded redox-active centers of metalloenzymes.8-10 On one hand, great progress has been 
made toward the enhancement of electron transfer in the construction of enzyme-based 
biosensors, by utilizing mediators, promoters or other special materials such as peroxidases.8-10 
On the other hand, higher sensitivity is achievable via the integration of nanomaterials, due to 
their capacity for the intimate attachment of enzymes, which is enabled by their higher surface 
area, roughness, and extensive number of available binding sites, as well as their unique 
physical, electronic and chemical properties.  
1.2.1. Enzyme-based biosensors 
Because enzyme-based sensors tend to either produce or consume protons and/or electroactive 
species, the vast majority of enzyme sensors employ an electrode as the transducer, which will 
be the primary emphasis of this dissertation. To date, from a practical and commercial point of 
view, biosensors for the detection of only four compounds have been widely used: glucose 
(diagnosis and treatment of diabetes, food science, biotechnology), lactate (sports medicine, 
critical care, food science, biotechnology), urea (clinical applications), and glutamate/glutamine 
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(food science, biotechnology). However, glucose biosensors are by far, the most widely 
employed. Hence, there are ongoing research efforts being applied toward their improvement. 
Devices that are capable of monitoring blood glucose in vivo, as part of an “artificial pancreas”, 
have been the subject of extensive research by many groups over the last few decades.11-13  Most 
enzyme-based biosensors employ a class of enzymes known as oxidoreductases, and the two 
most frequently encountered subclasses are the oxidases and dehydrogenases. Their reaction 
sequences may be described by the following reactions: 
  
 
If, for example, glucose oxidase (GOx) is the enzyme employed, then Sred, Sox, S'ox, and S'red 
correspond to glucose, gluconic acid, oxygen, and hydrogen peroxide, respectively. To make 
reaction eq 1 rate limiting, a large excess of S'ox (typically oxygen) is required. This is 
accomplished by increasing the flux ratio of Sred to S'ox into the enzyme reaction layer such that 
S'ox is in large excess. When properly implemented, the sensor output is largely independent of 
oxygen partial pressure over a wide range down to 8 Torr. (Levels of oxygen in subcutaneous 
tissue are estimated at 20−30 Torr). 14  
The rate of the overall reaction sequence can be measured by monitoring the 
consumption of S'ox or the formation of S'red. In practical GOx systems this relates to either the 
consumption of oxygen or the production of peroxide. The advantage of the former approach is 
the relative ease of separation of oxygen from other electroactive species through the use of a 
gas-permeable membrane. The disadvantage of this approach is that it is more complicated, 
requiring two measurements (concentration of oxygen in the presence and absence of the 
enzymatic reaction). However, it is capable of compensating for a significant fluctuation in 
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oxygen levels.15 The measurement of peroxide has the advantage of being simpler, especially for 
small sensors. The drawback, however, is that a number of in vivo endogenous species 
(ascorbate and urate) are electroactive at the applied potential required for peroxide oxidation. It 
has been proven possible to use permselective membranes that may successfully exclude 
interfering species.16 Monitoring of peroxide reduction is not possible because of the inability to 
find a potential at which peroxide, but not oxygen, is reduced. A porous Teflon membrane has 
been used to electrochemically detect hydrogen peroxide because of its “gaslike” properties,17 
thus enabling selectivity.  
It is clear then, that two redox couples are necessary to carry out the enzyme-catalyzed redox 
reaction, one of which is the analyte. Thus, the other (S'ox) must be introduced in some fashion. It 
is often desirable for the biosensor to be “reagentless”. This means that a clever method for 
delivering the second substrate (cofactor) must be devised, or S'ox must initially be present at 
sufficiently elevated levels that it does not affect sensor response. This is the reason for the 
overwhelming preference for oxidases, as oxygen is often naturally already present at the 
required levels.  If the enzyme belongs to the dehydrogenase class, it will typically use NAD as a 
cofactor. Either NAD or NADH will have to be monitored electrochemically or by some other 
means. There are a large number of enzymes in this class, but the need to add reagent (NAD) and 
the relative complexity of NADH electrochemistry have precluded their use in in vivo 
applications.  
Alternatively, S'ox might be eliminated if the redox center of the enzyme was coupled directly to 
the electrode, thus making the electrode the “sink” for the electrons required to complete eq 2. 
With few exceptions, this has not proven to be feasible because enzyme redox centers are 
frequently well buried within the protein and thus, heterogeneous electron transfer is 
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prohibitively slow. Horseradish peroxidase, which is a very small enzyme, is able to 
communicate directly with the electrode in the case of carefully prepared carbon electrodes18 or 
through the use of 30 nm gold particles deposited on a gold electrode.19-20  
1.2.2 Nanomaterials as substrates for enzymes 
Compelling combinations of the dimensional, compositional, and geometric properties of 
nanomaterials are required to impart unique functionality and applications. With this aim, the 
synthesis of certain functional nanomaterials with well-defined morphologies that are capable of 
interacting with specific organic compounds and polymers are a significant and ongoing 
challenge. The spontaneous adsorption of organic molecules on a variety of nanomaterials can 
generate films that are only a single molecule in thickness. These nanoscale, self-assembled 
monolayer (SAM) films have been extensively used to engineer surfaces with well-defined 
properties. Their utility has been demonstrated over a wide range of applications, including 
wetting, adhesion, lubrication, patterning, and molecular recognition. Although many SAM 
systems have been investigated, alkanethiols adsorbed on gold have been shown to be the most 
successful combination. This pairing offers a variety of advantages, including the ability to 
precisely tune the interfacial properties of a surface through well-established organic synthetic 
methodologies, which have been developed in the preparation of custom ω-terminated 
alkanethiols. Alkanethiolate monolayers are moderately stable at room temperature; however, 
these films degrade over time and readily desorb upon moderate heating. This shortcoming limits 
the use of SAMs in applications involving elevated temperatures or harsh environments. 
Accordingly, the necessity of utilizing other adsorbates with multiple bonding moieties has been 
important toward the enhancement of the stability and versatility of nanostructure-based 
biosensors. Chitosan has been used in the fabrication of biosensing devices because of its 
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biocompatibility, biodegradability, multiple functional groups, as well as its solubility in acidic 
aqueous media 21-23.  This naturally occurring polymer contains primary amines, hydroxyl and 
acetyl groups, which under weakly acidic conditions are protonated and have a tendency for 
inducing electrostatic interactions with metallic nanostructures. 
Molecular electronic properties (molecular “electronics”) and interfacial molecular electron 
transfer have evolved over the past few decades as a result of investigations into the intimate 
interactions between nanometric substrates and biomolecules. Here, we have aimed at working 
on particular facets of this exciting and broad interdisciplinary area; namely experimental and 
theoretical aspects associated with biomolecular electrochemistry.  
 
1.3. Dissertation rationale and scope 
The central theme of this dissertation pertains to highlighting the critical roles that are 
played by the morphology and intrinsic properties of nanomaterials when they are applied in the 
development of biosensors. Therefore, the objectives of my research are: 
(1) Synthesis and characterization of novel, biocompatible, metal-based engineered 
nanomaterials  
(2) Study of the interactions between nanomaterials and bio-recognition elements toward 
the evolution of an efficient immobilization procedure 
(3) Development of electrochemical biosensors based on nanostructured materials for 
the detection of specific target biomolecules 
(4) Adjustment of nanomaterial dimensions in order to achieve optimum sensitivity, 
stability and response time 
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I anticipate that the above objectives and methods will culminate in the establishment of  
strategies for enabling biocompatibility, high sensitivity, selectivity, rapid response, 
miniaturization, and low cost for biosensing. 
 In the following chapters, recent achievements in the development of various simple 
approaches for the synthesis of diverse nanomaterials with a variety of geometries are reported, 
along with their potential applications in electrochemical biosensors.  
Chapter 2 will present a survey of existing biosensors along with a number of current 
issues that are thought to impede their performance.  Finally, future perspectives for this field 
will be examined.  In chapter 3, a general procedure for the fabrication of reported biosensors 
will be discussed. In chapter 4, we report on a novel glucose biosensor that is based on the 
immobilization of glucose oxidase (GOx) on a Prussian blue modified nanoporous gold surface. 
The morphology and composition of the gold nanostructures were characterized by scanning 
electron microscopy (SEM), energy-dispersive X-ray spectroscopy (EDS).  We describe a highly 
sensitive electrochemical biosensor for the determination of total cholesterol in chapter 5. The 
cholesterol biosensor was fabricated by the co-immobilization of three enzymes, including 
cholesterol oxidase (ChOx), cholesterol esterase (ChE) and horseradish peroxidase (HRP), on 
nanoporous gold networks, which were grown directly on a titanium substrate. The morphology 
and composition of the fabricated nanoporous gold were characterized by scanning electron 
microscopy (SEM), energy-dispersive X-ray spectroscopy (EDS) and X-ray diffraction 
spectroscopy (XRD). The electrochemical behaviour of the cholesterol biosensor was studied 
using cyclic voltammetry. In chapter 6, we report on a novel platform based on buckypaper for 
the design of high-performance electrochemical biosensors.  Using glucose oxidase as a model 
enzyme, we constructed a biocompatible mediator-free biosensor and studied the potential effect 
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of the buckypaper on the stability of the biosensor with both amperometry and FTIR 
spectroscopy. In chapter 7, we present a new methodology for the synthesis of carbon-modified 
titanium oxide (TiO2) nanowires with controllable size. The surface morphology of a carbonized 
nanosensor network was further characterized for different sizes of nanowires. Upon enzyme 
immobilization, an electrochemical biosensor was developed for the detection of glucose in a 
human serum sample. To test the efficacy of nanomaterials in the direct oxidation of glucose, we 
report on a non-enzymatic palladium-cadmium (Pd-Cd) electrode in chapter 8. A hydrothermal 
method was applied in the synthesis of Pd-Cd nanoparticles. The non-enzymatic electrode was 
fabricated via the deposition of a Pd-Cd nanoparticle array on a glassy carbon electrode using 
Nafion. Direct glucose oxidation on the electrode was investigated in detail and we discuss the 
effect of electrode adhered nanomaterials on the electrocatalytic oxidation of glucose. Finally, in 
chapter 9, we conclude with a look at future challenges and prospects as relates to various 
aspects involved with the synthesis and application of nanomaterials-based biosensors.  
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Chapter 2 
Literature Review 
2.1. Introduction 
2.1.1. Definitions 
A chemical sensor is a device that transforms chemical information, ranging from the 
concentration of a specific sample component to total composition analysis, into an analytically 
useful signal. Chemical sensors typically contain two basic components connected in series: a 
chemical (molecular) recognition system (receptor) and a physico-chemical transducer. 
Biosensors are chemical sensors in which the recognition system utilizes a biochemical 
mechanism (Figure 1.1).1 The biological recognition system translates information from the 
biochemical domain, usually an analyte concentration, into a chemical or physical output signal 
with a defined sensitivity. The main purpose of the recognition system is to provide the sensor 
with a high degree of selectivity for the analyte to be measured. While all biosensors are more or 
less selective (non-specific) for a particular analyte, some are (by design and construction), only 
class-specific, since they use certain classes of enzymes, (e.g., phenolic compound biosensors, or 
whole cells used to measure biological oxygen demand). 
For the sensing systems that are present within living organisms, including olfaction, taste, 
and neurotransmission pathways, actual recognition is performed by cell receptors. Hence, the 
term receptor or bioreceptor is also often employed to denote the recognition system of a 
chemical biosensor. These examples are limited to the most common sensing principles, 
excluding existing laboratory instrumentation systems. 
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occurs only at a specific angle and wavelength of incident light and is highly dependent on the 
surface attributes of the gold, such that the binding of a target analyte to a receptor on the gold 
surface produces a measurable signal. 
Surface plasmon resonance sensors operate using a sensor chip that consists of a plastic 
cassette that supports a glass plate, one side of which is coated with a microscopically thin layer 
of gold. This is the side that contacts the optical detection apparatus of the instrument. The 
opposite side is then interfaced with a microfluidic flow system. Contact with the flow system 
creates channels across which reagents may be passed in solution. This side of the glass sensor 
chip can be modified in a number of ways to allow for the easy attachment of molecules of 
interest. Normally it is coated with carboxymethyl dextran or similar compounds. 
Light of a fixed wavelength is reflected from the gold side of the chip at the angle of total 
internal reflection and is detected inside the instrument. This induces the evanescent wave to 
penetrate through the glass plate and some distance into the liquid that is flowing over the 
surface. 
The refractive index at the flow region of the chip surface has a direct influence on the 
behaviour of the light that is reflected from the gold region. Binding to the flow region of the 
chip has an effect on the refractive index and in this way biological interactions may be 
measured with a high degree of sensitivity when facilitated by a source of energy. 
Other evanescent wave biosensors have been commercialised that utilize waveguides 
where the propagation constant through the waveguide is altered by the absorption of molecules 
to the waveguide surface. One such example, Dual Polarisation Interferometry uses a buried 
waveguide as a reference against which the change in propagation constant is measured. Other 
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configurations such as the Mach-Zehnder have reference arms lithographically defined on a 
substrate. Higher levels of integration may be achieved using resonator geometries where the 
resonant frequency of a ring resonator changes when molecules are absorbed.   
Other optical biosensors are based primarily on changes in absorbance or fluorescence of 
an appropriate indicator compound and do not need a total internal reflection geometry. For 
example, a fully operational prototype device for the detection of casein in milk has been 
fabricated. The device is based on detecting changes in absorption of a gold layer.2 A widely 
used research tool; the microarray, may also be considered a biosensor. 
Biosensors often incorporate a genetically modified form of a native protein or enzyme. 
The protein is configured to detect a specific analyte and the ensuing signal is read by a detection 
instrument such as a fluorometer or luminometer. An example of a recently developed biosensor 
is one for detecting cytosolic concentrations of the analyte cAMP (cyclic adenosine 
monophosphate).  cAMP is a second messenger that is involved in cellular signalling, which is in 
turn triggered by ligand - receptor interactions on the cell membrane.3 Similar systems have been 
created to study cellular responses to native ligands or xenobiotics (toxins or small molecule 
inhibitors). Such "assays" are commonly utilized in drug discovery development by 
pharmaceutical and biotechnology companies. Most cAMP assays in current use require the lysis 
of the cells prior to the measurement of cAMP. A live-cell biosensor for cAMP may be used in 
non-lysed cells with the additional advantage of multiple reads for studying receptor response 
kinetics. 
 
 

18 
 
circuit potential biosensors that are based on conjugated polymeric immunoassays. They contain 
only two electrodes and are extremely sensitive and robust; enabling the detection of analyte 
levels that were previously only achievable by HPLC and LC/MS, without rigorous sample 
preparation. The signal is generated by electrochemical and physical modifications in the 
conductive polymer layer due to changes that occur at the surface of the sensor. Such alterations 
may be attributed to ionic strength, pH, hydration and redox reactions. The latter is due to the 
enzyme label turning over a substrate (IUPAC). 
2.2.2. Receptor: Biological recognition element 
2.2.2.1. Biocatalytic recognition element    
In this instance, the biosensor is based on a reaction that is catalyzed by macromolecules, 
which are either inherently present in biological environments, previously isolated or 
manufactured. Thus, the continuous consumption of substrate(s) is achieved by the immobilized 
biocatalyst that is incorporated into the sensor: transient or steady-state responses are monitored 
by the integrated detector. Three types of biocatalysts are commonly used: 
1. Enzymes (e.g., mono- or multi-enzymes), which are the most common and well developed 
recognition system; 
2. Whole cells (e.g., microorganisms, such as bacteria, fungi, eukaryotic cells or yeast), cell 
organelles or components thereof (e.g., mitochondria, cell walls); 
3. Tissues (e.g., plant or animal tissue layers). Biocatalytic biosensors are the most well known 
and studied and therefore, have been the most frequently applied to biological matrices since the 
pioneering work of Clark.5 One or more analytes; typically named substrates S and S´, react in 
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the presence of enzyme(s), whole cells or tissue cultures and yield single or multiple products, P 
and P´, according to the general reaction scheme: 
S+S´               P+P´ 
There are four strategies that utilize adjacent transducers for monitoring the analyte S 
consumption by this biocatalysed reaction: 
 detection of the co-substrate S´ consumption (e.g., oxygen depleted by oxidase), bacteria 
or yeast reacting layers, and the corresponding signal decrease from its initial value; 
 recycling of P, one of the reaction products (e.g., hydrogen peroxide, H+, CO2, NH3, etc.). 
Production by oxidoreductase, hydrolase, lyase, etc., and corresponding signal increase; 
 detection of the state of the biocatalyst redox active centre, cofactor, prosthetic group 
evolution in the presence of substrate S, using an immobilized mediator which reacts 
sufficiently rapidly with the biocatalyst and is easily detected by the transducer; various 
ferrocene derivatives, as well as quinones, quinoid dyes, Ru or Os complexes in a 
polymer matrix, have been used; 
 direct electron transfer between the active site of a redox enzyme and the electrochemical 
transducer 
The third strategy attempts to eliminate sensor response dependence on the co-substrate, S´ 
concentration and to decrease the influence of possible interfering species. The first goal is 
reached only when the reaction rates are much higher for immobilized mediators with 
biocatalysts than those for co-substrates with biocatalysts. 
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An alternative approach to the use of such mediators consists in restricting the analyte 
(substrate) concentration within the reaction layer through an appropriate outer membrane, 
whose permeability strongly favours co-substrate transport. When multiple enzymes are 
immobilized within the same reaction layer, a number of strategies for improving biosensor 
performance may be developed. The following three possibilities have been most frequently 
proposed:6-7 
 several enzymes facilitate biological recognition by sequentially converting the product 
of a series of enzymatic reactions into a final electroactive form: this set-up allows for a 
much wider range of possible biosensor analytes; 
 multiple enzymes applied in series may regenerate the first enzyme co-substrate and a 
real amplification of the biosensor output signal may be achieved by the efficient 
regeneration of another co-substrate of the first enzyme; 
 multiple enzymes, applied in parallel, may improve biosensor selectivity by decreasing 
the local concentration of electrochemical interfering substances: this set-up is an 
alternative to the use of either a permselective membrane or a differential set-up, i.e., 
subtraction of the output signal generated by the biosensor and by a reference sensor 
having no biological recognition element. 
2.2.2.2. Biocomplexing or bioaffinity recognition element 
Biosensor operation is based on the interaction of analytes with macromolecules or 
organized molecular assemblies that have either been isolated from their original biological 
environment or engineered.8 Thus, equilibrium is usually attained and there is no further net 
consumption of the analyte by the immobilized biocomplexing agent. These equilibrium 
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responses are monitored by an integrated detector. In some cases, the biocomplexing reaction 
itself is monitored using a complementary biocatalytic reaction. Steady-state or transient signals 
are then monitored by the integrated detector. 
1. Antibody-antigen interaction. The most developed examples of biosensors using 
biocomplexing receptors are based on immunochemical reactions, i.e. binding of an antigen (Ag) 
to a specific antibody (Ab). The formation of such Ab-Ag complexes must be detected under 
conditions where non-specific interactions are minimized. Each Ag determination requires the 
production of a particular Ab, its isolation and typically, its purification. Several studies have 
been described that involved the direct monitoring of the Ab-Ag complex formation on Ion 
Sensitive Field-Effect Transistors (ISFETs). In order to increase the sensitivity of 
immunosensors, enzyme labels are frequently coupled to Ab or Ag, thus requiring additional 
chemical synthesis steps. Even in the case of the enzyme-labelled Ab, these biosensors will 
essentially operate at equilibrium, where the sole function of the enzymatic activity is to quantify 
the amount of complex produced. 
2. Receptor:antagonist:agonist. More recently, attempts have been made in employing ion 
channels, membrane receptors or binding proteins as molecular recognition systems in 
conductometric, ISFET, or optical sensors. For example, the transport protein, lactose permease 
(LP), may be incorporated into liposomal bilayers, thus allowing for the coupling of sugar proton 
transport with a stoichiometric ratio of 1:1, as demonstrated when the fluorescent pH-probe 
pyranine is entrapped within these liposomes.9 These LP-containing liposomes have been 
incorporated within planar lipid bilayer coatings of an ISFET that is gate sensitive to pH. 
Preliminary results have shown that these modified ISFETs enable the rapid and reversible 
detection of lactose in a FIA system. Protein receptor-based biosensors have been recently 
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developed.10 The result of the binding of the analyte (termed agonist here), to immobilized 
channel receptor proteins, is monitored by changes in ion fluxes through these channels. 
2.3. Biosensor construction 
2.3.1. Immobilization of biological receptors 
Since the development of enzyme-based biosensors for glucose (first described by Clark in 
1962), in which glucose oxidase was entrapped between two membranes,5 an impressive volume 
of literature that describes techniques of immobilization and related biosensor development has 
appeared. These methods have been extensively reviewed elsewhere.1, 11 Biological receptors, 
i.e. enzymes, antibodies, cells or tissues with high biological activity, may be immobilized within 
a thin layer at the transducer surface by using different procedures. The following protocols are 
the most generally employed (Figure 3.2):   
1. Entrapment behind a membrane: a solution of enzyme, suspension of cells or a slice of tissue 
is simply confined by an analyte permeable membrane as a thin film, which covers the 
electrochemical detector;12 
2. Entrapment of biological receptors within a polymeric matrix such as polyacrylonitrile, agar 
gel, polyurethane (PU) or poly(vinyl-alcohol) (PVAL) membranes, sol gels or redox hydrogels 
with redox centers;13 
3. Entrapment of biological receptors within self-assembled monolayers (SAMs) or bilayer lipid 
membranes (BLMs);14 
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4. Covalent bonding of receptors onto membranes or surfaces activated by means of bifunctional 
groups or spacers such as glutaraldehyde, carbodiimide, SAMs or multilayers, avidin-biotin 
silanization.  Several of these activated membranes are commercially available;15 
5. Bulk modification of an entire electrode material, (e.g., enzyme modified carbon paste or 
graphite epoxy resin).16 
 
Figure 2.3. Scheme of primary types of enzymatically modified electrodes.17 (A) Membrane 
electrode; (B) Modification of the electrode surface through adsorption; (C) Covalent bonding; 
(D) Gel/polymer entrapment; (E) Entrapment via crosslinking; (F) Entrapment of the enzyme-
containing material in a carbon-paste electrode; (G) Antigen-Antibody assembly on an electrode. 
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Receptors are either individually immobilized or mixed with additional proteins, such as 
bovine serum albumin (BSA), directly on the transducer surface, or on a polymeric membrane 
that covers it. In the latter case, pre-activated membranes can be used directly for enzyme or 
antibody immobilization without the requirement of further chemical modification of the 
membrane or macromolecule. 
Apart from the final example, reticulation and covalent attachment procedures are more 
complex than those that involve entrapment, but are especially useful in cases where the sensor is 
so diminutive that the appropriate membrane must be fabricated directly onto the transducer. 
Under such conditions more stable and reproducible activities may be obtained via covalent 
attachment. 
2.4. Biosensor applications   
There are myriad potential applications of biosensors of various classes. The chief 
prerequisites for a biosensor approach in terms of its value in research and for commercial 
applications include the identification of a target molecule, the availability of a suitable 
biological recognition element, and the potential for disposable portable detection systems as 
preferable to sensitive laboratory-based techniques in particular situations. A number of 
examples are given below:14-17 
 Glucose monitoring for diabetes patients (historical market driver). 
 Other medical/health-related targets. 
 Environmental applications (e.g., detection of pesticides in ecosystems and water resident 
contaminants). 
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 Remote sensing of airborne bacteria (e.g., in counter-bioterrorist activities). 
 Detection of pathogens. 
 Determination of toxic substance levels prior to and following bioremediation. 
 Detection and quantification of organophosphates. 
 Routine analytical measurement of folic acid, biotin, vitamin B12 and pantothenic acid as 
an alternative to microbiological assay. 
 Determination of drug residues in food, such as antibiotics and growth promoters, 
particularly in meat products and honey. 
 Drug discovery and the evaluation of biological activity of new compounds. 
 Protein engineering in biosensors. 
 Detection of toxic metabolites such as mycotoxins 
2.4.1. Electrochemical glucose biosensor in diabetes management 
Diabetes is a rapidly growing problem; the number of people with diabetes increased from 
153 million in 1980, to 347 million in 2008.18 In 2004, an estimated 3.4 million people died as a 
result of the consequences of high blood sugar. This number is estimated to double by 2030.19 
Diabetes may lead to serious complications such as lower limb amputations, blindness, as well as 
cardiovascular and kidney disease. 
There are three types of diabetes: 
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1. Type 1 diabetes usually affects the young and occurs when the pancreas no longer produces 
any (or very little) insulin. Approximately 10% of diabetics have Type 1. 
2. Type 2 diabetes commonly affects middle-aged or older patients and occurs when the pancreas 
does not produce enough insulin or when the body does not use the insulin that is produced 
effectively. 90% of people with diabetes have Type 2. 
3. Gestational diabetes is a temporary condition that occurs during pregnancy. It affects 2–4% of 
all pregnancies with an increased risk of developing diabetes for both mother and child 
Glycaemia and diabetes are on the rise globally and are driven by population growth, 
ageing and an increasing age-specific prevalence. Effective preventive interventions are 
essential, and health systems should prepare to sufficiently detect and manage diabetes and its 
sequel. To attain optimal control, patients must currently monitor their blood glucose levels. This 
requires a patient to obtain a small sample of blood, usually via a finger prick. Blood is placed 
onto a sensor test strip that is then read by a handheld electronic reader, which reports the blood 
glucose concentration. These sensors are based on electrochemical enzymatic measurements 
with screen-printed electrodes that provide rapid and accurate measurements of blood glucose 
without the need for laboratory analysis. However, there are limitations to this approach 
including painful sampling; analyses cannot be performed if the patient is otherwise occupied 
(e.g., sleeping); and large fluctuations between sampling intervals can be missed.20 To facilitate 
the resolution of inherent problems with discrete blood glucose measurement, new commercial 
products focus on continuous glucose interrogation.  Early stage nanotechnology and 
nanomedical research involving nanosensors and nanomaterials is also focussed on continuous 
monitoring. 
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2.4.1.1. Brief history of electrochemical glucose biosensor 
The first glucose biosensor was fabricated by entrapping a layer of glucose oxidase (GOx) 
within a semipermeable dialysis membrane on an oxygen electrode. The amount of consumed 
oxygen in the enzyme-catalyzed reaction was proportional to the concentration of glucose: 
 
To measure consumed oxygen, a negative potential was applied to the platinum cathode and the 
reduced form of oxygen was evaluated: 
 
This discovery prompted further research in field of biosensors. Efforts to develop and 
improve glucose sensors have been made over the last five decades since Clark and Lyons 
reported the first enzyme electrode in 1962.5 Updike and Hicks21 further developed this principle 
by using dual oxygen working electrodes (one was coated with enzymes) and measuring the 
differential current in order to correct for the oxygen background variation in samples. In 1973, 
Guilbault and Lubrano22 described an enzyme electrode for the measurement of blood glucose 
that was based on the amperometric (anodic) monitoring of the hydrogen peroxide product 
 
The resulting biosensor offered good accuracy and precision when tested with 100 μL 
blood samples. During the 1980‟s, biosensors became a „hot‟ topic; reflecting a growing 
emphasis on biotechnology. Considerable efforts during this decade focused on the development 
of mediator-based „second-generation‟ glucose biosensors;23 the introduction of commercial 
screen-printed strips for self-monitoring of blood glucose;24 and use of modified electrodes and 
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tailored membranes/coatings for enhancing sensor performance.25 In the 1990s, we witnessed 
extensive activity directed toward the establishment of electrical communication between the 
redox center of GOx and the electrode surface.
26-28 Of particular note is the work of Heller, who 
introduced the use of a flexible polymer with osmium redox sites.26 During this period, we also 
witnessed the development of minimally invasive subcutaneously implantable devices.29 
Figure 2.4 summarizes various generations of amperometric glucose biosensors based on 
different mechanisms of electron transfer, including the use of natural secondary substrates, 
artificial redox mediators, or direct electron transfer. Although substantial progress has been 
made on the electronic coupling of GOx, further improvements in the charge transport between 
its FAD redox center and electrodes are desired. 
2.4.1.2. First generation glucose biosensor 
First-generation glucose biosensors relied on the use of the natural oxygen co-substrate and 
generation and the detection of hydrogen peroxide (eqs 1 and 3). The biocatalytic reaction 
involves reduction of the flavin group (FAD) in the enzyme by reaction with glucose to give the 
reduced form of the enzyme (FADH2). Then, the flavin may be re-oxidized by molecular oxygen 
to regenerate the oxidized form of the enzyme GOx (FAD). Hydrogen peroxide gets reduced as a 
product of this reaction. Measurements of peroxide formation have the advantage of being 
simpler, especially when miniaturized devices are concerned. 
2.4.1.2.1. Electroactive Interferences 
The measurement of hydrogen peroxide at high voltage in a glucose sensor is subject to 
interference from electroactive species in blood. Electrochemical interferents in blood can cause  
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Figure 2.4. Standard GOx-based electrochemical biosensors (A, B) use a GOx layer to recognize 
glucose and generate an electrochemical signal. This signal is transferred from the enzyme 
through O2 reduction to H2O2 (A: first generations sensors) or the reduction of another chemical 
mediator (B: second generation sensors). Nanomaterials can be incorporated into these sensors to 
increase surface area, improve catalytic action, modify operating parameters and improve 
electron transfer from the enzyme to the electrode. This can be accomplished through the use of 
single types of nanomaterials (C: single-nanomaterial sensors) such as CNTs, or nanocomposites 
consisting of multiple nanomaterials working together (D: nanocomposite sensors).30 
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a false high glucose reading by donating non-glucose-derived electrons. A list of suggested 
“standard” interferents, developed by the FDA, is shown in Table 1.1, along with interferent 
concentrations obtained from the National Center for Clinical Laboratory Standards. (NCCLS 
Guideline EP7-P, Interference Testing in Clinical Chemistry). Strips are tested at low glucose 
concentrations, with and without the specified interferents, in order to determine the signal 
increment due to interferents. From the compounds listed in Table 1.1, those most likely to 
electrochemically interfere are ascorbate, acetaminophen, and urate. One useful avenue in 
diminishing electroactive interferences is to employ a permselective coating that minimizes the 
access of these constituents toward the electrode surface. Different polymers, multilayers, and 
mixed layers with transport properties based on charge, size, or polarity have thus far been used 
for blocking coexisting electroactive compounds.12, 31-34 
Such films also exclude surface-active macromolecules, hence protecting the surface and 
imparting higher stability. Electropolymerized films, particularly poly(phenylendiamine), 
polyphenol, and overoxidized polypyrrole, have been shown to be extremely useful in imparting 
high selectivity (by rejecting interferences based on size exclusion) while confining GOx onto the 
surface.31 The electropolymerization process makes it possible to generate coatings on extremely 
small surfaces with complex geometries, although the resulting films often have limited stability 
for in vivo work. Other commonly used coatings include size-exclusion cellulose acetate films,12 
the negatively charged (sulfonated) Nafion or Kodak AQ ionomers,33 and hydrophobic 
alkanethiol or lipid layers.34 Use of overlaid multilayers, which combines the properties of 
different films, offers additional advantages. For example, the alternate deposition of Nafion and 
cellulose acetate has been used to eliminate the interference of the neutral acetaminophen and 
negatively charged ascorbic and uric acids, respectively.35 
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Table 2.1 List of Potential Electrochemical Interferentsa 
interferent suggested test level (mg/dL) ref 
Acetaminophen 20 1 
salicylic acid 50 1 
tetracycline 4 1 
dopamine 13 1 
ephedrine 10 2 
ibuprofen 40 1 
l-DOPA 5 3 
methyl-DOPA 2.5 1 
tolazamide 100 2 
Tolbutamide 100 1 
ascorbic acid 3 1 
bilirubin (unconjugated) 20 1 
cholesterol 500 1 
creatinine 30 1 
triglycerides 3000 1 
urate 20 1 
a (1) From NCCLS Document EP7-P; (2) Calculated assuming that the drug, at 10 times the 
dosage rate, becomes promptly available in 5 L of blood. (3) 10 times the maximum plasma 
concentration.36 
 
Another approach to minimize the interferents effect is to detect the released hydrogen 
peroxide at the optimal operating potential (+0.0 to -0.20 V vs Ag/AgCl) where contributions 
from easily oxidizable interfering substances are eliminated.37 Remarkably high selectivity, 
coupled with a fast and sensitive response has thus been obtained. In particular, Prussian-Blue 
(PB; ferric−ferrocyanide) modified electrodes have received considerable attention owing to 
their very strong and stable electrocatalytic activity.37-40 Prussian-Blue offers a substantial 
lowering of the overvoltage for the hydrogen peroxide redox process and hence permits highly 
selective biosensing of glucose at a very low potential (-0.1 V vs Ag/AgCl). The high catalytic 
activity of PB leads also to a very high sensitivity toward hydrogen peroxide. Further 
improvements in the stability and selectivity of PB-based hydrogen peroxide transducers can be 
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obtained by electropolymerizing a non-conducting poly(1,2-diaminobenzne) permselective 
coating on top of the PB layer.39 A glucose nanosensor, based on the co-deposition of PB and 
GOx on a carbon-fiber nanoelectrode, has also been reported.40 PB-based carbon inks were 
developed for fabricating electrocatalytic screen-printed glucose biosensors.38 
2.4.1.3. Second generation glucose biosensor 
Since first generation glucose biosensors rely on the use of oxygen as the physiological 
electron acceptor, they are subject to errors resulting from fluctuations in oxygen tension and the 
stoichiometric limitation of oxygen. These errors include changes in sensor response and a 
reduced upper limit of linearity. Further improvements and solutions to the aforementioned 
drawbacks may be obtained by replacing the oxygen with a non-physiological (synthetic) 
electron acceptor that is capable of shuttling electrons from the redox center of the enzyme to the 
surface of the electrode. The transfer of electrons between the GOx active site and the electrode 
surface is the limiting factor in the operation of amperometric glucose biosensors. Glucose 
oxidase does not directly transfer electrons to conventional electrodes because of a thick protein 
layer that surrounds its flavin adenine dinucleotide (FAD) redox center, thus introducing an 
intrinsic barrier to direct electron transfer. Accordingly, different innovative strategies have been 
suggested for establishing and tailoring the electrical contact between the redox centers of GOx 
and electrode surfaces. Use of non-physiological electron acceptors,41 wired enzyme electrodes, 
42 modification of GOx with electron relays
26 and nanomaterial connectors are some of the 
approaches. Among them, nanomaterials have been of more interest due to their unique and 
controllable properties. 
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2.4.1.3.1. Nanomaterial connectors 
A defining characteristic of nanomaterials is that they have at least one structural 
dimension of the order of 100 nm or less.43 Nanomaterials and nanosensors offer some 
significant advantages owing to their small size. High surface area/volume ratios (allowing larger 
signals, better catalysis and the more rapid movement of analytes through sensors), as well as 
enhanced optical properties (quantum dot fluorescence, gold nanoparticle quenching, surface-
enhanced Raman scattering (SERS)) represent significant benefits over macroscale materials. 
Researchers have used these properties to improve the accuracy, size, lifetime and usability of 
sensors for the treatment of diabetes. Nanosensors are finally nearing the stages of commercial 
and clinical implementation, which will hopefully allow better treatment for patients suffering 
from diabetes in the future. 
The most common application of nanotechnology for sensors in diabetes is the use of 
nanomaterials to assist the standard enzymatic electrochemical detection of glucose. The 
incorporation of nanomaterials into these sensors offers a variety of advantages including 
increased surface area; more efficient electron transfer from enzyme to electrode; and the ability 
to include additional catalytic steps. Although a detailed discussion of all possible modifications 
to standard electrodes would be prohibitively long, we highlight recent advances that 
demonstrate the range of options for nanomaterials in glucose sensors. 
Carbon nanotube (CNT) incorporation is a heavily investigated modification to the 
enzymatic electrode detection of glucose, partly because of the electron transfer capabilities of 
CNTs as well as their large surface areas. The electrode can be replaced with a highly porous 
nanofiber onto which glucose oxidase is immobilized.44 This structure has a much higher 
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electronic surface area than do bulk metal electrodes and accordingly, may immobilize more 
enzymes and generate larger signals. Another approach is to modify the nanotubes with an 
electrochemical mediator such as ferrocene to improve the electron transfer between the enzyme 
and electrode.45 
CNTs can be coupled with other nanomaterials or polymers to form nanocomposites for glucose 
detection. Combining CNTs with additional nanomaterials improves aspects such as catalytic 
activity. Nanocomposite membranes have recently been fabricated with the layer-by-layer 
assembly of CNTs and gold nanoparticles.37, 46 Similar approaches have also coupled CNTs with 
metal nanoparticles of silver,47 platinum,48 as well as non-metals such as silica.49 
A variety of nanostructured electrodes can improve conventional macrostructured 
electrodes. Zinc oxide deployed as nanotube arrays50 has been used for glucose detection. 
Nanowire arrays fabricated from ruthenium51 and gold52 have an increased surface area and 
improved electrochemical interrogation compared with conventional electrodes. In addition to 
creating nanoscale features on the surface of the electrode, nanostructures can be generated with 
nanoparticles. Gold,37 platinum,53 and palladium54 nanoparticles have been used in membranes to 
enhance electron transfer and increase the surface area of the sensor. 
Magnetic nanoparticles, commonly made from iron oxide, have also been used for glucose 
sensors.55-56 The magnetic nature of these nanoparticles simplifies the assembly of GOx-labeled 
nanoparticles onto the electrode,55 as well as enabling the formation of nanoparticle comprised 
conductive wires on the electrode surface.56 In both of these examples, the nanoparticles were 
attracted to the electrode surface using magnetic fields, which highlights one advantage in using 
magnetic nanoparticles in the fabrication of nanoparticle electrode assemblies. 
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Nanostructured polymers can improve the development of glucose sensors. Hollow spheres 
of conductive polymers can be used to transfer electrons from GOx to the electrode.
57 Conductive 
polymer electrodes can be used in a method similar to other nanostructured surfaces, where GOx 
is immobilized directly on the modified electrode. In one example, the electrode surface was 
covered with highly ordered polyaniline nanotubes, which had GOx immobilized within the 
tubes.58 The use of polymers introduces a range of different electrochemical properties, including 
operation at varying potentials. The use of different potentials helps to minimize electrochemical 
interference from common electroactive compounds in blood (e.g., acetaminophen, ascorbic acid 
and uric acid), which can cause non-specific signals with standard electrochemical detection 
approaches. 
Coupling biological recognition elements with electrochemistry increases the selectivity 
and sensitivity of sensors and explains both the popularity of this approach and the commercial 
success of sensors that are based on proteins. Despite these advantages, there are several 
drawbacks to sensors based on biological recognition, including intrinsically poorer stability in 
comparison with non-biological systems. As a result of this limitation, many research groups 
have focused on the development of glucose detection assays that do not rely on a protein for 
recognition and as a result, could have longer storage lifetimes. 
One of the most heavily researched areas in relation to non-enzymatic glucose sensors is 
the detection of glucose oxidation directly at an electrode. However, this method also has several 
limitations such as slow reaction kinetics and the need for a large applied potential, which 
decreases specificity.59 Nanomaterials have helped to overcome these limitations and thereby 
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allowed the development of direct oxidation glucose sensors as replacements for biological 
recognition sensors. 
Nanomaterial-based sensors can also be designed to detect glucose through changes in pH 
or charge, often through a field effect transistor (FET). These devices measure a property of the 
nanomaterial (such as conductance) that is affected by charges near the surface of the sensor or 
the pH of the solvent. As the concentration of glucose changes, the charge near the surface or the 
pH changes either as a result of enzymatic reactions or competitive binding, causing the sensor to 
register a change in the measured property. This allows for the indirect quantification of glucose 
concentration, although pH changes in the bulk solution can affect the measured response. 
The breakdown of glucose catalyzed by GOx decreases solution pH by liberating hydrogen 
ions and generates negative charges by producing the gluconate ion. Risveden and colleagues 
used a region-selective ion-sensitive field effect transistor (RISFET) to detect gluconate 
generation to quantify glucose concentrations. The RISFET focuses the gluconate between the 
sensing electrodes, whereby an increase in current is proportional to the amount of glucose 
present. The layer-by-layer assembly of CNTs with GOx allows the change in pH generated by 
glucose degradation to be monitored by measuring the conductance changes in the CNT layer.60 
Modified nanoparticles can also improve the sensitivity of capacitive electrolyte-insulator-
semiconductor (EIS) structures. The use of gold nanoparticles modified with both GOx and 
ferrocene improved sensitivity nearly two-fold over nanoparticles modified with only GOx.
61 In 
addition to using GOx to recognize glucose, other proteins such as concanavalin A (ConA), a 
plant lectin that binds polysaccharide, can be used in FET detection platforms. A CNT-based 
FET labelled with the polysaccharide dextran has been shown to detect a change in resistance 
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upon binding, or in the presence of glucose, the displacement of ConA with picomolar detection 
limits.62 
2.4.1.4. Third generation glucose biosensor 
Ultimately, one would like to eliminate the mediator and develop a reagentless glucose 
biosensor with a low operating potential, close to that of the redox potential of the enzyme. In 
this case, the electron is transferred directly from glucose to the electrode via the active site of 
the enzyme. The absence of mediators, which is the main advantage of new generations of 
biosensors, may lead to very high selectivity (owing to the very low operating potential). 
However, as discussed earlier, critical challenges must be overcome for the successful realization 
of this direct electron-transfer route owing to the spatial separation of the donor−acceptor pair. 
Efficient direct electron transfer at conventional electrodes has been reported for only a few 
redox enzymes. There are mixed reports in the literature regarding the direct (mediatorless) 
electron transfer catalyzed by GOx.
63 Although several papers claim such direct electron transfer 
between GOx and the electrode, only a few provide a sufficient level of proof for such 
mediatorless detection. Unsuccessful efforts in obtaining direct electron transfer of GOx at 
conventional electrodes has led to the exploration of new electrode materials. Optimally 
designed electrode configuration must ensure that the electron-transfer distance between the 
immobilized protein and the surface is made as short as possible. One route for creating third-
generation amperometric glucose biosensors is to use conducting organic salt electrodes based on 
charge-transfer complexes such as tetrathiafulvalene-tetracyanoquinodimethane (TTF-TCNQ). 
64-65 Different electron-transfer mechanisms at TTF-TCNQ electrodes have been proposed by 
different authors, and the precise mechanism of GOx catalysis remains controversial. Khan et al. 
described a third-generation amperometric glucose sensor based on a stable charge-transfer 
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complex electrode.65 The device relied on the growing tree-shaped crystal structure of TTF-
TCNQ. The authors claimed that the close proximity and favorable orientation of the enzyme at 
the crystal surface allowed for the direct oxidation of the enzyme and selective glucose 
measurements at 0.1 V (vs Ag/AgCl), although they did not furnish convincing evidence for such 
direct electron transfer. Mediatorless third-generation glucose biosensors based on the 
GOx/polypyrrole system were suggested by Yabuki and Koopal.
15, 66 However, the relatively 
high anodic potential of this system (vs the redox potential of FAD/FADH2, -0.44 V) suggests 
the possibility of electron transfer mediated by oligomeric pyrroles present on the surface. 
Recently developed, oxidized boron-doped diamond electrodes have indicated some promise for 
mediator-free glucose detection based on direct electron transfer.67 
2.4.1.5. Continuous glucose monitoring 
The traditional monitoring of blood glucose uses discrete blood sampling time points 
during the course of a day. For many diabetics this provides satisfactory data for the control of 
blood glucose levels. However, current technology for continuous glucose monitoring has some 
disadvantages that have prevented its widespread adoption for the management of diabetes. All 
FDA approved devices are implanted sensors, which have a maximum useful lifetime of several 
days to a week (partially because the immune system responds to the sensor as a foreign body). 
Because they are implanted in subcutaneous tissue, these sensors do not directly sample blood, 
and this can lead to a lag time in measurements taken during periods of rapid concentration 
changes. This lag time has been estimated to be from several minutes to nearly 30 minutes. 
Additionally, current sensors must be calibrated and checked against standards because they are 
only approved for tracking trends in blood glucose levels. Finally, current sensors are expensive 
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and are not always covered by health insurance plans, therefore this technology has not been 
widely adopted.30 
2.4.1.5.1. Requirements 
The major requirements of clinically accurate in vivo glucose sensors have been discussed 
in several review articles.29, 68 The ideal sensor would be one that provides reliable real-time 
continuous monitoring of all blood glucose variations throughout the day with high selectivity 
and speed over extended periods under harsh conditions. The challenges for meeting these 
demands include rejection of the sensor by the body, miniaturization, long-term stability of the 
enzyme and transducer, oxygen deficit, in vivo calibration, short stabilization times, baseline 
drift, safety, and convenience. The sensor must be of a very tiny size and proper shape that 
allows for easy implantation and results in minimal discomfort. Last but not least, is the 
formulation of workable strategies for powering of an autonomous sensor-transmitter system. 
Reducing the size of the power source (e.g., biofuel cell, battery) remains a major challenge. 
Undesirable interactions between the surface of the implanted device and the biological 
medium can cause the deterioration of sensor performance upon implantation, and has proved to 
be the major barrier in the development of reliable in vivo glucose probes. Such adverse effects 
include the effect of the sensor upon the host environment, as well as the effect of the 
physiological environment on sensor performance. In blood, the major source of complication 
arises from the surface fouling of the electrode via proteins and coagulation composites, leding 
to the risk of thromboembolism. Due to this severe blood-induced biofouling, which suppresses 
the glucose response, most glucose biosensors lack the capacity for the sustained 
biocompatibility that is necessary for reliable and prolonged operation in whole blood. The 
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danger of thrombus formation is another major concern (health risk) that hinders the 
implementation of sensors that are implanted for access to the blood. Accordingly, the majority 
of sensors that are being developed for continuous glucose monitoring do not measure blood 
glucose directly. 
Alternative sensing sites, particularly the subcutaneous tissue, have thus received growing 
attention. The subcutaneous tissue is minimally invasive and its glucose level reflects the glucose 
concentration of the blood. However, such subcutaneous implantation generates a wound site 
that experiences an intense localized inflammatory reaction. The inflammatory response that is 
associated with wound formation is characterized with problems such as scar tissue formation 
accompanied by the adhesion of bacteria and macrophages, which can distort the glucose 
concentration in the immediate vicinity of the sensor.69 The extent of this inflammatory response 
is dependent upon various factors, including the shape, size, and rigidity of the sensor, as well as 
its physical and chemical composition. 
Recent approaches for the design of more biocompatible in vivo glucose sensors have 
focused on the preparation of interfaces that resist biofouling. These include the controlled 
release of nitric oxide (NO),13, 69 protecting the outer surface with polymeric coatings (such as 
polyethylene glycols, polyethylene oxides, or the perfluorinated ionomer Nafion) that exhibit 
low protein adsorption,70-72 or co-immobilization of the anticoagulant heparin.73 The former is 
attributed to the discovery that NO is an effective inhibitor of platelet and bacterial adhesion. 
Such NO-release glucose sensors were prepared by doping the outer polymeric membrane 
coating of previously reported needle-type electrochemical sensors with suitable lipophilic 
diazeniumdiolate species72 or diazeniumdiolate-modified sol−gel particles.13 Histological 
examination of the implant site demonstrated a significant decrease in the inflammatory 
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response. Similarly, poly(ethylene glycol) (PEG) containing polymers are among the least 
protein absorbing. Quinn et al. reported on a glucose permeable hydrogel based on crosslinking 
an eight-armed amine-terminated PEG derivative with a di-succinimidyl ester of a dipropionic 
acid derivative of PEG.71 The gel was evaluated as a biocompatible interface between an 
amperometric glucose microsensor and the subcutaneous tissue of a rat. Very few adherent cells 
were observed after seven days. 
A key issue is the maintenance of calibration over a period of several days. The calibration 
process should be repeated during implantation to account for variations in sensitivity. A 
calibration-free operation is the ultimate goal, but this would require a detailed understanding of 
the sensitivity changes along with highly reproducible devices. 
2.4.2. Cholesterol biosensor 
The assertion that elevated plasma cholesterol concentrations may lead to an increased 
chance of developing either atherosclerosis or coronary heart disease (CHD) is now long 
established74 and has become a central tenet of the “lipid hypothesis”. The need to limit dietary 
fat and cholesterol intake was recognised by the UK government in the 1992 Health of The 
Nation Report,75 and in the United States from the recommendations of the National Research 
Council.76 Nevertheless, the role of cholesterol remains controversial. It is not yet clear whether 
cholesterol is a causal agent for inducing atherosclerosis, or if it is the primary exacerbating 
factor in the formation of foam cells after initial artery wall injury via some other means. The 
requirement for the accurate determination of serum cholesterol has, as a consequence, 
stimulated a large amount of work on the development of methods for its assay that are fast 
enough for routine assay, whilst simple and reproducible. Serum cholesterol analysis is currently  
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generally accomplished by using a three-enzyme assay and indicator method as originally 
devised by Richmond et al.77 Since ≈70% of the cholesterol present in serum samples is 
esterified, a typical assay for total serum cholesterol usually begins with the incubation of serum 
with cholesterol esterase in order to isolate free cholesterol, which is amenable to oxidation with 
cholesterol oxidase. A peroxidase enzyme subsequently reduces the hydrogen peroxide that is 
produced when one molecule of cholesterol is oxidized. Oxidation of an indicator molecule in 
turn reactivates the peroxidase and produces a chromogen, which when measured, facilitates the 
indirect estimation of total serum cholesterol. 
Several versions of this procedure exist14 and the separation of these steps has been found 
to give a better test accuracy than a one-step procedure.78 However, only a few cholesterol 
biosensors have been successfully commercially launched. One of the reasons for this originates 
from the optimization of critical parameters, such as enzyme stabilization, quality control and 
instrumentation design. The cholesterol biosensor must be easy to use, self-testing, fast response 
and portable, etc. Further, the proper marketing of the product is essential for attracting the 
attention of potential users. Increased understanding of immobilized bioreagents, improved 
immobilization techniques and technological advances in microelectronics are likely to speed up 
the commercialization of a much needed cholesterol biosensor. 
2.5. Conclusion and perspectives 
Applications of biosensors to address practical problems are related to health, food, or 
energy supply. A variety of methodologies are envisaged to expand the area of biosensors to 
additional analytical tasks. For example, the development of new biosensors may be seen as 
essential to solving the inherent difficulties of a variety of challenging in situ and in vivo 
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analyses. Although other types of biosensors exist; in all cases, an important challenge that 
remains is the miniaturization of biosensors, which imparts dual advantages: (i) limits the 
amount of immobilized enzyme, and (ii) yields tools for direct use and possible implantation in 
living tissues. The increased integration of biological materials within these patterned structures 
may be accomplished through the use of nanostructures. Subsequently, very promising pathways 
toward the development of “ideal” amperometric biosensors have been opened. 
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Chapter 3 
Materials and Methods 
3.1. Introduction 
In the previous chapters, we presented an overview of the biosensor, its applications, the 
issues that the current biosensing systems encountered, along with the objectives of this 
dissertation. In this chapter, the main experimental methodology and techniques employed in this 
research project will be described briefly. 
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3.2.1. Materials 
Glucose oxidase (EC 1.1.3.4, Type VII from Aspergillus Niger) and D-glucose were 
purchased from Sigma and used as received. Chitosan was purchased from Aldrich. HAuCl4 
(99.9%), PdCl2 (99.9%), and Cd(NO3)2 (99.9%) from Alfa Aesar. Ferric chloride (FeCl3) was 
purchased from Anachemia, and potassium ferricyanide (III) (K3Fe(CN)6) and ammonium 
formate (99.995%) from Sigma–Aldrich.  
Cholesterol oxidase (from Streptomyces species), cholesterol esterase (from hog pancreas), 
cholesterol, and Triton® X-100 (t-octylphenoxypolyethoxyethanol) were purchased from Sigma, 
4-cholesten-3-on from Aldrich, titanium plates (99.2%) from Alfa Aesar and lactic acid from 
Fluka. Horseradish peroxidase, ascorbic acid, uric acid, lactic acid, sodium phosphate dibasic 
and sodium phosphate monobasic were used as received from Sigma-Aldrich.  
The buckypaper used in this study was produced by the High-Performance Materials 
Institute of Florida State University with a thickness of 0.035 mm. 
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Water was purified with the Nanopure® water system (18 MΩ cm) and was used to prepare 
all solutions and clean all materials. All experiments were performed in a 0.1 M phosphate buffer 
solution (PBS) with different pH values maintained with K2HPO4 and KH2PO4. 
Various stock concentrations of β-D-glucose and cholesterol were prepared in 0.1M 
phosphate buffer, pH 7.4 and stored at 4 ºC. Glucose stock solutions were allowed to mutarotate 
overnight prior to use. 
At least five independent trials were carried out to generate each data set obtained in each 
individual experiment. 
3.2.2. Instruments and electrochemical experiments 
Surface morphology and composition of the synthesized samples were characterized using 
scanning electron microscopy (SEM) (JEOL JSM 5900LV) equipped with an energy-dispersive 
X-ray spectrometer (EDS) (Oxford Links ISIS). Surface elemental compositions based on 
quantitative EDS analysis were reported in average values of readings taken at five different 
spots on each sample surface. The X-ray diffraction (XRD) patterns of the as-prepared samples 
were recorded using a XRD Philips PW 1050-3710 diffractometer with Cu Kα radiation. Field-
emission scanning electron microscopy (FE-SEM) (Hitachi, SU-4800), transmission electron 
microscopy (TEM) (JOEL 2010F) were utilized to characterize the morphology and composition 
of the buckypaper. FTIR spectra were recorded using a NICOLET 8700 FTIR (Thermo 
Scientific, USA). 
All electrochemical experiments were performed using an electrochemical workstation 
(CHI660B, CH instrument Inc.), connected with an in-house-built, three-electrode glass cell (30 
mL). A platinum coil was used as the counter electrode and was flame-annealed before each 
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experiment. An Ag/AgCl (saturated KCl) electrode was used as the reference electrode. The 
fabricated electrodes were used as the working electrode. All measurements were conducted at 
room temperature (22 ± 2 °C). Figure 3.1. shows the dimention of the working, reference and 
counter electrodes which were consistent in all of the fabricated biosensors. 
 
 Figure 3.1. A photograph of a typical working, reference and counter electrodes. 
 
3.2.3. Fabrication of electrodes 
3.2.3.1. Biosensor fabrication 
The titanium (Ti) substrate plates (~1 cm2) were first degreased in an ultrasonic bath of 
acetone for 10 min. followed by 10 min. in pure water (18 MΩ). The substrates were then etched 
in 18% HCl at approximately 85 °C for 30 min.  
The gold and palladium/cadmium nanostructure materials were synthesized by a hydrothermal 
method. In the hydrothermal method, the etched Ti substrates were transferred into Teflon-lined 
autoclaves, along with a given amount of an aqueous mixture of inorganic metal precursors and a 
reducing agent. The autoclaves were sealed and heated at 180 oC for a given period of time. The 
Ti plates coated with nanomaterials were dried and annealed under argon at 250 °C for 2 h. 
Prussian blue (PB) was deposited onto the nanoporous Au surface by electrodeposition. 
This was accomplished by immersing the nanoporous Au electrode in a solution containing 
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FeCl3 + K3Fe(CN)6 + KCl + HCl and applying a constant potential for a given period of time. 
Afterwards, the electrode was placed into a supporting electrolyte solution and electrochemically 
activated by cycling between a given ranges of potential.1  
The buckypaper was electrochemically activated before use.  To activate the buckypaper 
(BP) surface, cyclic voltammetry was performed in a given range of potential in a phosphate 
buffer solution (PBS) at pH 7.4 until a steady cyclic voltammogram was obtained, and then a 
potential of 1.5V was applied for 90s. This step led to the functionalization of the buckypaper 
with carboxlic groups. The activated surface was thus ready for the immobilization of enzymes.2 
Titanium dioxide (TiO2) nanowires were prepared using a H2O vapor assisted thermal 
oxidation process in the presence of potassium fluoride (KF). The procedure is described briefly 
below. Initially, a predetermined volume of KF solution was applied to the surfaces of pre-
treated Ti plates (etched in 18% HCl at 85˚C for 15 min), after which the Ti plates were 
transferred to a ceramic boat. The ceramic boat was next inserted into a quartz tube. After being 
purged with Argon for 1 h, the gas flow was switched to H2O vapour. Subsequently, the quartz 
tube was heated to different temperatures (500-700˚C), which were maintained for various time 
periods (1-5 h), as required. After thermal treatment, the input gas was switched back to a pure 
Argon flow until the furnace cooled to room temperature. Finally, the as-synthesized samples 
were rinsed several times using distilled water to remove any residual salts from the surfaces of 
the samples.  
In order to fabricate the carbon coated TiO2 nanowires, the as-synthesized TiO2 nanowire 
samples were inserted into a quartz tube.  After being purged with Argon for 1 h, the gas was 
switched to ethanol vapor. The quartz tube was then heated to 600 oC for different periods of 
time. Following thermal treatment, the input gas was switched back to pure Argon until the 
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furnace cooled to room temperature. The electrodes used in this work were carbonized under 
identical optimized conditions. We followed the same procedure to activate the carbon-modified 
TiO2 nanowire surface as we did for buckypaper.
2 
To immobilize the glucose oxidase (GOx), we applied different methods (chapters 4 & 6).
1-
2 briefly, a solution of the mixture of GOx and chitosan was cast onto the nanomaterials. In 
another approach a mixeture of GOx and Nafion
® was prepared and the nanomaterial coated 
substrates dipped into the mixed solution for an optimum amount of time.     
We used the multiple enzymes immobilization in cholesterol biosensor preparation. To 
immobilize the enzymes, a mixture of cholesterol oxidase (ChOx), horseradish peroxidise (HRP), 
cholesterol esterase (ChE) and chitosan was cast onto the nanoporous Au electrode substrate.3 
All prepared biosensors were stored at 4 ºC when not in use. 
To investigate the selectivity of the biosensors, we tested their response to common 
interfering species including ascorbic acid (AA), uric acid (UA) and acetamidophenol (AP) at 
their physiological concentration levels. Chronoamperometry was conducted upon the injection 
of each of the interference species (0.1 mM AA, 0.1 mM UA and 0.1 mM AP) followed by the 
glucose injections.  
To fabricate enzyme free glucose sensor, glassy carbon electrodes (GC, 3 mm in diameter, 
CH Instruments) were polished before each experiment with alumina powder, rinsed thoroughly 
with doubly distilled water and ultrasonicated in 1:1 HNO3, ethanol and water and allowed to dry 
at room temperature. Then, a solution of Pd-Cd nanoparticles in Nafion® (0.5% in methanol) 
were added on GC electrodes.  
3.2.2. Real sample analysis 
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3.2.2.1.Measurements of cholesterol in food and supplements samples  
The fabricated cholesterol biosensor was tested using real food samples. The amount of total 
cholesterol was measured in butter, margarine and fish oil by the fabricated biosensor. The real 
samples were prepared using the same procedure as the cholesterol standard solution described 
in chapter 5.3  The data was collected from five samples for each product.  
3.2.2.2. Measurement of glucose in human serum samples 
 These measurements were performed by chronoampermetry at the potential range of -0.5 to 0.3 
V for 100 s in human serum samples. The human serum was derived from male AB plasma 
(from Sigma). Comparison tests were performed with a commercially available Blood Glucose 
Monitoring System with the brand name of Ultra2®. The data were collected from five samples 
for each concentration.  
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Chapter 4 
Glucose Biosensing based on the Highly Efficient Immobilization of 
Glucose Oxidase on a Prussian blue Modified Nanostructured Au 
Surface* 
4.1. Introduction 
Certain areas of medical, food and environmental analysis require express and inexpensive 
monitoring methods, e.g. for glucose in blood and food.1-3 Regarding its importance, growth in 
the world glucose monitoring industry is remarkable. There are many different methods to 
measure glucose concentrations, such as the  electromagnetic technique,4 Fluorescence 
spectroscopy,5 fourier transform infrared and near infrared spectroscopy,6,7 Raman 
spectroscopy,8 NMR Spectroscopy,9 liquid chromatography-mass spectroscopy,10 laser diode 
array,11 high performance liquid chromatography,12 capillary and microchip electrophoresis,13-14 
polarography,15 and the electrochemical methods.16-17 In the area of electrochemical methods, 
biosensors represent an important subclass of sensors in which an electrode is used as the 
transduction element, and are highly qualified for meeting the size, cost and power 
requirement.18 The development of electrochemical glucose biosensors was progressive in recent 
years.19 Enzymatic biosensors performance is based on the electron transfer between enzyme and 
electrode. Moreover, enzyme-catalyzed reactions are prone to inhibition by molecules that 
interfere with the formation of product.20 Indeed, in an enzymatic electrode which is usually 
prepared by attaching an immobilized enzyme layer to an electrochemical sensor, changes 
occurring as a result of the enzyme reaction can be monitored either potentiometrically or 
                                                          
* Most of the results presented in this chapter have been published in Electrochemistry 
Communications, 2009, 11, 2048. 
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amperometrically.21-22 It has been also witnessed that   nanoparticles are able to enhance this 
electron transfer process. In this regard, owing to their large surface area and strong adsorption 
ability for enzyme immobilization, chemical stability, low inherent toxicity (biocompatibility) 
and conductivity,  gold nanoparticles have attracted particular interest in fabricating biosensors.23 
Prussian blue, ferric hexacyanoferrate, often provides some sort of activated surface due to 
its structure which facilitates enzyme immobilisation. In fact, it is an efficient redox mediator for 
selective detection of H2O2 in the presence of oxygen and other interferents.
24-28 Prussian blue 
can serve as an electrocatalyst by reduction of H2O2 and has been applied in the construction of a 
large number of oxidase enzyme-based glucose biosensors.29  
Glucose oxidase as an enzyme catalyses the oxidation of β-D-glucose to D-glucono-1,5-
lactone and hydrogen peroxide, using molecular oxygen as the electron acceptor. It is a dimeric 
protein with a molecular weight of 160 kDa, containing one tightly bound (K = 1×10-10) flavin 
adenine dinucleotide (FAD) per monomer as cofactor. FAD functions as a coenzyme because of 
its ability to undergo reversible redox reactions. 
In this work, a glucose biosensor based on the Gold- Prussian blue nanoparticles is 
fabricated with immobilization of glucose oxidase onto the surface of the electrode. Due to the 
mentioned characteristics of gold and Prussian blue, the resulted biosensor displayed high 
enfficient enzyme immobilization, high sensitivity, low detection limit, good stability and 
improved lifetime. Details of the preparation and characterization of the fabricated biosensor are 
described in this study. 
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4.2.1. Materials 
Glucose oxidase (EC 1.1.3.4, Type VII from Aspergillus Niger) and D-glucose were 
purchased from Sigma and used as received. Chitosan was purchased from Aldrich, and HAuCl4 
(99.9%) from Alfa Aesar. Ferric chloride (FeCl3) was purchased from Anachemia, and 
potassium ferricyanide (III) (K3Fe(CN)6) and ammonium formate (99.995%) from Sigma–
Aldrich. All other reagents were of analytical grade. Water was purified with the Nanopure® 
water system (18 MΩ cm) and was used to prepare all solutions and clean all materials. All 
experiments were performed in a 0.1 M phosphate buffer solution (PBS) with different pH 
values maintained with K2HPO4 and KH2PO4.  
4.2.2. Glucose biosensor fabrication 
The Ti substrate plates (1.25 cm × 0.80 cm × 0.5 mm) were first degreased in an ultrasonic 
bath of acetone for 10 min. followed by 10 min. in pure water (18 MΩ). The substrates were then 
etched in 18% HCl at approximately 85 °C for 30 min. The etched Ti substrates were transferred 
into Teflon-lined autoclaves and 10 ml of an aqueous mixture of inorganic metal precursor and a 
reducing agent was added. 1 M ammonium formate was used as the reducing agent and the metal 
precursor was 10 mM HAuCl4. The autoclaves were sealed and heated at 180 
oC for 10 h. The Ti 
plates coated with Au were dried and annealed under argon at 250 °C for 2 h. After cooling to 
room temperature, Prussian blue (PB) was deposited onto the nanoporous Au surface by 
electrodeposition. This was accomplished by immersing the nanoporous Au (NPAu) electrode in 
a solution containing 2.5 mM FeCl3 + 2.5 mM K3Fe(CN)6 + 0.1 M KCl + 0.1 M HCl and 
applying a constant potential of +0.4 V for 4 min. Afterwards, the electrode was placed into a 
supporting electrolyte solution made of 0.1 M KCl + 0.1 M HCl and electrochemically activated 
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by cycling between a potential range of −0.05 and +0.4 V at a scan rate of 50 mV s−1 for 25 
cycles. To immobilize the enzyme GOx, a solution of the mixture of 20 μL of 9 mg mL
−1 of GOx 
and 10 μL of 2 mg mL−1 of chitosan was cast onto the PB modified nanoporous Au electrode 
(Ti/NPAu/PB/GOx). Chitosan was used to enhance the stability of the biosensor 
30.  
For comparison, a glucose biosensor based on a PB modified Au thin film (Ti/Au/PB/GOx) 
was also fabricated with the identical procedure. The Au thin film was coated onto the Ti 
substrate by argon plasma sputtering for 30 s. All prepared enzyme electrodes were stored at 
4 °C when not in use. 
4.2.3. Biosensor characterization and electrochemical measurements 
The morphology and composition of the nanoporous Au materials were characterized by 
scanning electron microscope (SEM) (JEOL JSM 5900 LV) at an acceleration voltage of 13 kV, 
and an energy-dispersive X-ray (EDS) spectrometer. The cyclic voltammograms (CVs) were 
acquired from −0.2 V to +0.3 V at a scan rate of 10 mV/s in 50 ml of 0.1 M pH 7.0 PBS. The 
amperometric response of the biosensor to glucose was recorded in a stirred PBS at -0.1 V versus 
the Ag/AgCl reference electrode. All electrochemical experiments were performed at room 
temperature, 20 ± 2 oC. 
 4.3. Results and discussion 
4.3.1. Characterization of the Ti/Au electrode surface  
Figure 4.1A and B present a typical SEM image and EDS spectrum of the Ti/NPAu 
electrode, respectively, fabricated using the hydrothermal method. The SEM image reveals that 
nanoporous Au networks were formed and completely covered the substrate. The three-
dimensional random porous structures, with diameters of tens to hundreds of nanometers, were 
formed by the close connection of the Au nanoparticles, with a size range of 50 to 500 nm. Only 
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Au peaks appear in the EDS spectrum, and no discernible carbon or oxygen signals are seen in 
the figure, showing that the synthesized Au-nanoporous networks are free of surface organic 
impurities. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.1. The typical SEM image of the nanoporous Au coating (A) and the corresponding 
EDS  spectrum (B). 
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4.3.2. Electrochemical behaviour of the PB modified Au electrodes 
Figure 4.2 displays the cyclic voltammograms of the PB modified Au electrodes recorded in a 
0.1 M PBS (pH=7.0) at a scan rate of 10 mV/s. A pair of well-defined oxidation and reduction 
peaks are observed for the Ti/Au/PB electrode (Plot a).  
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Figure 4.2. Cyclic voltammograms of  the Ti/Au/PB electrode (Plot a), the Ti/NPAu/PB 
electrode (Plot b) and the Ti/NPAu/PB/GOx electrode (Plot c) recorded in a 0.1 M PBS (pH=7.0) 
at a scan rate of 10 mV/s. 
 
The anodic and cathodic peak potentials are located at +0.052 V and -0.016 V, 
respectively. The formal potential E0 was calculated to be +0.018 V. The redox peaks 
significantly increase at the Ti/NPAu/PB electrode (Plot b), showing that the nanoporous Au 
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directly grown on the Ti substrate hydrothermally possesses a much higher surface area than the 
sputtered Au thin film. The oxidation and reduction peaks originate from the redox process of 
Prussian white (Fe4
3+[Fe2+(CN)6]3) and Prussian blue (K4Fe4
3+[Fe2+(CN)6]3) . 
31  
After we immobilized the enzyme GOx on the Ti/NPAu/PB surface, the redox peaks 
decreased as seen in Plot c. The immobilized GOx blocks some of the redox reaction sites, 
indicating the successful immobilization of GOx on the PB modified nanoporous Au surfaces. 
4.3.3. Response of the glucose biosensor 
The electrochemical characterization of the biosensor was investigated by cyclic 
voltammetry.  
 
 
Figure 4.3. Cyclic voltammograms of the Ti/NPAu/PB/GOx electrode in the absence (a) and in 
the presence of 1 mM glucose (b) at the scan rate of 20 mV.s-1 in 0.1 M PBS (pH 7.0). 
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Figure 4.3 presents the CV curves recorded in 0.1M PBS (pH=7.0) at a scan rate of 20 
mV/s in the absence of glucose (a) and in the presence of 1 mM glucose (b). It is seen that the 
reduction current increases while the oxidation current decreases, which relates to the oxidation 
of glucose by GOx catalysis. The mechanism for the reaction for the detection of glucose can be 
defined as follows:32 
 
D-glucose + O2              gluconolactone +  H2O2                                         (1)  
K4Fe4
2+[Fe2+(CN)6]3 + 2H2O2               Fe
3+[Fe2+(CN)6]3 +4OH
- +4K+         (2) 
Fe4
3+[Fe2+(CN)6]3+ 4e
- + 4K+ K4Fe4
2+[Fe2+(CN)6]3                           (3)        
   
The impact of the applied electrode potential and pH of the PBS on the amperometric 
response of the Ti/NPAu/PB/GOx electrode to glucose was investigated, revealing the optimized 
sensing conditions: the applied potential of -0.1 V and pH = 7. Figure 4.4A displays the steady-
state amperometric response of (i) the Ti/Au/PB/GOx electrode and (ii) the Ti/NPAu/PB/GOx 
biosensor recorded by successively adding glucose into the PBS under the optimized sensing 
conditions. 
 For the Ti/NPAu/PB/GOx biosensor, 95% of the steady-state current was achieved at less 
than 15 s. The corresponding calibration curves for the two electrodes are shown in Figure 4.4B. 
The amperometric response of the Ti/NPAu/PB/GOx biosensor is much higher than that of the 
Ti/Au/PB/GOx electrode. A linear relationship of the current to the concentration of glucose was 
observed between 0 and 2.04 mM with a correlation coefficient of 0.9993 with 17 successive 
injections of 0.12 mM glucose. The sensitivity of the Ti/NPAu/PB/GOx biosensor is extremely 
high, 177 µA/mM. The detection limit is estimated to be 2.5 µM glucose (based on S/N = 3).  
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Figure 4.4.  (A) Amperometric response to successive additions of 0.12 mM glucose into a 0.1 
M pH 7.0 PBS under the applied electrode potential –0.1 V; (B) the corresponding calibration 
curves for the response of : (i) the Ti/Au/PB/GOx and (ii) Ti/NPAu/PB/GOx electrode. 
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To evaluate the biological activity of the immobilized GOx, the apparent Michaelis-Menten 
constant Km is generally used 
22. According to the Michaelis-Menten equation:  
Imax/Is = Km/C+1 
Where I is the steady-state catalytic current, Imax is the maximum current measured under 
saturated conditions, C refers to the glucose concentration and Km stands for the apparent 
Michaelis-Menten constant. This equation allows us to plot the experimental 1/Is vs. 1/C to 
determine Km. According to our experimental data, Km was evaluated as 2.1 mM. The value of 
Km is much lower than the reported 4.3 mM for gold nanoparticles ,
31 19 mM for ZnO nanotubes 
,33 and 21.1 mM  for microband gold electrodes. 34 The small Km value indicates that the 
immobilized GOx possesses high enzymatic activity and that the fabricated biosensor exhibits a 
high affinity for glucose. Table 4.1 shows a comparison between the proposed biosensor and the 
other relevant studies. 
 
Table 4.1 The comparison between the proposed biosensor and the other Prussian blue based 
glucose biosensors. 
Electrode Detection limit 
µM 
Linear range 
mM 
Km 
mM 
Sensitivity 
µA.mM.cm-2 
AuE/PB/GOx
32 3.1 0.06-1.60 N/A 83.8 
TiO2NT/Au/PB/GOx
35 5.0 0.015-4.0 N/A 36 
PB/CS/Au/GOx
26 39.7 0.001-0.4 3.73 81.8 
This work 2.5 0.1-2.04 2.1 177 
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4.3.3. Selectivity and stability of biosensor 
We further studied the selectivity of the fabricated Ti/NPAu/PB/GOx biosensor. The 
amperometric response of the biosensor to successive additions of common interfering 
substances and glucose in0.1 M PBS (pH = 7.0) was measured under the applied electrode 
potential -0.1 V. As shown in Figure 4.5, the biosensor shows no or very little response to 
ascorbic acid (AA), uric acid (UA), and acetaminophen (AP); in contrast, the biosensor exhibits 
very strong response to the successive injections of 0.1 mM glucose in the presence of 0.1 mM 
AA, 0.2 mM UA and 0.1 mM AP, indicating that the glucose biosensor fabricated in this study 
has a very high anti-interferent ability.  
 
Figure 4.5. Effect of interferents, 0.1 mM ascorbic acid (AA), 0.1 mM acetaminophen and 0.02 
mM uric acid (UA), on the response of the Ti/NPAu/PB/GOx biosensor to successive additions 
of 0.1 mM glucose.  
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The reproducibility of the biosensor was also examined by measuring the response towards 1mM 
glucose in 50 ml pH 7.0 PBS. Four biosensors constructed independently gave a relative standard 
deviation (R.S.D.) of 4.2%.  The long-term stability of the biosensor was evaluated by measuring 
its performance every week. The biosensor retained around 85% of the initial response after four 
weeks. After 60 days, the biosensor was still very active, retaining over 70% of the initial 
response. 
4.4. Conclusions 
In this chapter, we have demonstrated a novel glucose biosensor based on the highly 
efficient immobilization of GOx on a PB modified nanoporous Au surface. The nanoporous Au 
was directly grown through a facile hydrothermal method and modified by electrodeposited 
Prussian blue. Our study has shown that the PB modified nanoporous Au substrate provides an 
excellent matrix for the immobilization of GOx owing to its large surface area and strong 
adsorption ability for enzyme binding, high chemical stability, low inherent toxicity and high 
conductivity. The small Km value of the Ti/NPAu/PB/GOx biosensor indicates that the 
immobilized GOx possesses high enzymatic activity and that the fabricated biosensor exhibits a 
high affinity for glucose. Our electrochemical tests show that the fabricated Ti/NPAu/PB/GOx 
biosensor exhibits fast amperometric response, a low detection limit (2.5 μM), extremely high 
sensitivity (177 μA mM-1), good reproducibility, high anti-interferent ability and long-time 
stability.  
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Chapter 5 
High Performance Electrochemical Biosensor for the Detection of 
Cholesterol* 
5.1. Introduction 
Cholesterol is made by the liver as well as being part of a healthy dietary intake of fats. 
Cholesterol and triglycerides are important building blocks in the structure of cells and are used 
in making hormones and vitamin D, and producing energy. However, having a high total 
cholesterol (the sum of free cholesterol and cholesterol esters) level, particularly those of the low 
density lipoprotein type, can cause blood vessel damage and resulting diseases such as coronary 
heart disease and peripheral vascular disease. High cholesterol has also been linked to nephrosis, 
diabetes mellitus, myxedema and jaundice. On the other hand, a low cholesterol level may result 
in hyperthyroidism, anemia and maladsorption.1 Most recent studies have shown that high 
cholesterol can affect macrophages which are part of the innate immune system that typically 
gobble up pathogens and clear away dead cells.2 The desired total plasma cholesterol for an 
individual is less than 5.2 mM (200 mg/dl), with a high level being considered as greater than 
6.2mM (240 mg/dl).1 Thus, the industrial and clinical determination of cholesterol is of great 
interest.3-5  
Electrochemical biosensors offer several distinct advantages. These devices are uniquely 
qualified for meeting the small size, inexpensive, low volume and power requirements of 
decentralized testing and show great promise for a wide range of biomedical and environmental 
applications.6 In the development of electrochemical biosensor, facilitation of the electron 
                                                          
* Most of the results presented in this chapter have been published in Biosensors and 
Bioelectronics, 2011, 26, 4508. 
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transfer between the enzyme and the electrode is a great challenge because of the deeply 
embedded redox-active center of the metalloenzyme. On one hand, great efforts have been made 
to enhance the electron transfer in sensor design by using mediators, promoters or other special 
materials such as peroxidases for the construction of enzyme-based biosensors.6-8 On the other 
hand, with the use of nanomaterials, higher sensitivity and the intimate attachment of enzymes 
are achievable due to the nanomaterials’ high surface roughness as well as their unique physical, 
electronic and chemical properties. Applications of nanostructured materials have been attracting 
great attention in the development of high-performance electrochemical biosensors. Among 
them, gold nanomaterials have gained particular interest due to their ease of synthesis and 
functionalization, high chemical stability, low inherent toxicity (biocompatibility), and tunable 
optical and electronic properties.9-10 It has been reported that the above mentioned properties of 
Au nanomaterials can effectively facilitate the electron transfer in the design of an 
electrochemical biosensor.11-13 Few biosensors have been reported for cholesterol determination 
compared with those reported for glucose; thus, developing biosensors based on gold 
nanostructures for the detection of total cholesterol may have a significant impact on both the 
clinical diagnostics and the food industry.  
To develop the electrochemical cholesterol biosensor, Aravamudhan et al. attached the 
enzymes to the surface of aligned-gold nanowires through direct physical adsorption.3  Their 
studies showed the fabricated biosensor with the sensitivity of 0.85 µA.mM-1 and the Michaelis-
Menten constant of 17.1 mM. To improve the sensitivity,  Gopalan et al. recently reported on the 
fabrication of a biosensor for the detection of free cholesterol by combining the advantageous 
features of MWNT (multi-walled carbon nanotubes), Au nanoparticles, chitosan and ionic 
liquid.14 Chitosan, a polysaccharide composed mainly of β-(1,4)- linked 2-deoxy-2-amino-D-
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glucopyranose units, is the deacetylated product of chitin, poly (N-acetyl-D-glucosamine). 
Chitosan has been used for the fabrication of biosensing devices because of its biocompatibility, 
biodegradability, multiple functional groups, as well as its solubility in acidic aqueous 
medium.12, 15-16   
Given the huge medical implications, the industrial and clinical determination of 
cholesterol is increasingly important. Since 70% of cholesterol exists in ester form and 30% as 
free form in a blood sample, detection of the total cholesterol is desirable. In the present work, 
for the first time, we co-immobilized three enzymes, cholesterol oxidase (ChOx), cholesterol 
esterase (ChE) and horseradish peroxidase (HRP), on the nanoporous Au networks with the aid 
of chitosan for the detection of the total cholesterol. The nanoporous Au networks were directly 
grown on a titanium (Ti) substrate using the hydrothermal method. The fabricated biosensor was 
free of any other promoters or special materials toxic to the environment and human. Our 
electrochemical measurements show that the fabricated cholesterol biosensor has high 
sensitivity, a very low Michaelis-Menten constant, a wide linear range, low detection limit, high 
selectivity and excellent stability. The cholesterol biosensor developed in this study was further 
tested using real food samples, indicating the promising applications in both clinical diagnostics 
and the food industry. 
5.2. Experimental 
5.2.1. Materials 
Cholesterol oxidase (from Streptomyces species), cholesterol esterase (from hog pancreas), 
cholesterol, glucose, and Triton® X-100 (t-octylphenoxypolyethoxyethanol) were purchased 
from Sigma, 4-cholesten-3-on from Aldrich, titanium plates (1.25 cm × 0.8 cm × 0.5 mm, 
99.2%) from Alfa Aesar and lactic acid from Fluka. Horseradish peroxidase, ascorbic acid, uric 
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acid, lactic acid, sodium phosphate dibasic and sodium phosphate monobasic were used as 
received from Sigma-Aldrich. Nanopure water (18.2 MΩ cm) was used to prepare all solutions. 
All other chemicals were analytical grade and were used as received from commercial sources. A 
stock solution of cholesterol was prepared by dissolving cholesterol in isopropanol, then adding 
Triton X-100 and finally the phosphate buffer (pH 7.4) in a volume ratio of 10: 4: 86. 
5.2.2. Preparation of the cholesterol biosensor 
The hydrothermal method used in fabricating the nanoporous gold networks is similar to 
the previous studies.17-19 Briefly, titanium plates (1.25 cm×0.8 cm) were washed in acetone, 
followed by Nanopure water, and then etched in a solution of 18% wt hydrochloric acid at 85 °C 
for 10 min to remove the oxide layer and roughen the Ti surface. The etched Ti substrates were 
transferred into Teflon-lined autoclaves containing 10 mL of an aqueous mixture of inorganic 
metal precursor and a reducing agent. A 1.0 M ammonium formate solution was used as the 
reducing agent and the metal precursor was HAuCl4. The autoclaves were sealed and heated at 
180 ºC for 10 h. The Ti plates coated with Au were dried and annealed under argon at 250 ºC for 
2 h. After final rinsing with pure water, the Ti plates coated with nanoporous gold were ready for 
further surface analysis and for the immobilization of enzymes. To immobilize the enzymes, a 
mixture of 20 µL of 2 mg mL-1 of cholesterol oxidase (ChOx), 10 µL of 2 mg mL
-1 horseradish 
peroxidase (HRP), 10 µL of 2 mg mL-1 of cholesterol esterase (ChE) and 10 µL of 2 mg mL-1 of 
chitosan was cast onto the nanoporous Au electrode (Ti/NPAu/ChOx-HRP-ChE). Chitosan was 
used as a glue to enhance the stability of the biosensor.20-21 All prepared biosensors were stored 
at 4 ºC when not in use. 
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5.2.3. Instruments and Electrochemical Experiments 
Surface morphology and composition of the synthesized samples were characterized using 
scanning electron microscopy (SEM) (JEOL JSM 5900LV) equipped with an energy-dispersive 
X-ray spectrometer (EDS) (Oxford Links ISIS). Surface elemental compositions based on 
quantitative EDS analysis were reported in average values of readings taken at five different 
spots on each sample surface. All electrochemical experiments were performed using an 
electrochemical workstation (CHI660B, CH instrument Inc.), connected with an in-house-built, 
three-electrode glass cell (30 mL). A platinum coil was used as a counter electrode and was 
flame-annealed before each experiment. An Ag/AgCl (saturated KCl) electrode was used as the 
reference electrode. The fabricated Ti/NPAu/ChOx-HRP-ChE electrodes were used as the 
working electrode. All potentials reported in this paper are referred to the Ag/AgCl (saturated 
KCl) reference electrode. Cyclic voltammetric measurements of cholesterol were carried out in a 
0.1 M phosphate buffer solution (pH 7.4) at selected potential ranges. All measurements were 
conducted in a 30 mL solution and at room temperature (22 ± 2 °C). 
5.3. Results and discussion 
5.3.1. Surface morphological studies 
Figure 5.1A and B present a typical SEM image at ×15,000 magnification and EDS 
spectrum of the nanoporous gold (Ti/NPAu) electrode, respectively, fabricated using the 
hydrothermal method.  The SEM image shows that nanoporous gold structure was formed and 
completely covered the substrate and that the thickness of the nanoporous gold layer was around 
0.4 μm. The diameter of the formed randomly porous structures varies from tens to hundreds of 
nanometers. Only Au and Ti peaks appear in the EDS spectrum, and no discernible carbon or 
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oxygen signals are seen in the figure, showing that the synthesized nanoporous Au is free of 
surface organic impurities. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.1. SEM image of the nanoporous Au directly grown on a titanium substrate and the 
corresponding EDS spectrum. 
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 The XRD pattern of the as-synthesized Ti/NPAu surface is shown in Figure 5.2. All 
diffraction peaks originate from the Au film and the Ti substrate. The lattice constant calculated 
from the pattern was 4.079 Å, consistent with the literature a = 4.078 Å (Joint Committee on 
Powder Diffraction Standards file no. 04-0784). The XRD analysis reveals that the agglomerated 
structure observed by SEM has an average crystallite size of 22 nm. As seen in the experimental 
section, only inorganic metal precursors and diluted reducing agent were  
 
Figure 5.2. (A) (B). (C) XRD spectrum recorded from the synthesized nanoporous Au. 
involved in the direct growth of nanoporous Au on the Ti substrate. The above results show that 
the one-step hydrothermal reduction process is an environmentally friendly approach and does 
not require any further separation and purification of the formed nanoporous Au with a large 
surface area, which is ready for the immobilization of enzymes. The surface roughness of 
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nanoporous Au was calculated by integrating the Au oxide reduction peak area obtained from the 
cyclic voltammogram in 50 mM H2SO4, then, dividing by the geometrical surface area. The 
surface roughness for nanoporous Au was 5.9. 
5.3.2. Electrochemical characterization 
The electrochemical responses of the Ti/AuNPs/ChOx-HRP-ChE electrodes were studied 
by cyclic voltammetry (CV). Figure 5.3A shows the bioelectrocatalytic behaviour of the enzyme 
electrode recorded in a phosphate buffer solution (pH 7.4) in the potential range of -0.8 to 0.4 V 
at different scan rates. For instance, at the scan rate of 50 mV s-1, the cathodic and anodic peaks 
appear at -0.36 and -0.047 V, respectively.  The formal potential, E0=1/2 (Ep,a + Ep,c), was 
calculated to be -0.203V (vs. Ag/AgCl) and the electroactive enzyme amount, Γ =Q/nFA, 
(Where Q is the integrated charge which is calculated based on the peak area under the I-E curve, 
n is the electron number transferred, F the faraday constant, and A is the geometric surface area 
of the working electrode) is 2.1×10-9 mol.cm-2. This is higher than the experimental values 
7.52×10-10 and 4.7×10-10 mol.cm-2 22-23 for the monolayer of flavoenzymes reported in literature. 
The higher value can be ascribed to the efficient immobilization of the enzymes on the 
nanoporous gold surface with high conductivity and a large surface area. 
As seen in Figure 5.3B, both the anodic and cathodic peak currents increase linearly with 
the scan rates, indicating that the pair of redox waves originates from the surface confined 
molecules. The anodic and cathodic peak potentials also change as a function of the scan rate (10 
– 300 mV s-1). With increasing the scan rate, the oxidation peak shifts to more positive 
potentials, while the reduction peak shifts to more negative potentials. The anodic and cathodic 
peak potentials are linearly dependent on the logarithm of the scan rates (ν) when ΔEp > 200/n 
where n is the number of electron transferred. This is in agreement with Laviron theory.24-25 
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Figure 5.3. (A) Cyclic voltammamograms of the Ti/AuNPs/ChOx-HRP-ChE electrode at 
different scan rates (10, 20, 30, 40, 50, 100, 150, 200, 250, 300 mVs-1) in a phosphate buffer (pH 
7.4). (B) Plot of anodic and cathodic peak currents vs. scan rates. (C) Variation of peak potentials 
vs. the logarithm of the scan rates. 
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The plots of Ep versus log ν are displayed in Figure 5.3C, yielding two straight lines with 
slopes of -2.3RT/αnF and 2.3RT/(1−α)nF for the cathodic and anodic peaks, respectively. Thus, 
experimental α was estimated to be 0.36.  
The effect of pH on the performance of the Ti/NPAu/ChOx-HRP-ChE electrodes was 
investigated in 0.1M phosphate buffer solutions with the pH varied from 4.0 to 9.0 at the scan 
rate of 50 mV/s. The current response was found to be maximum at pH 7-8, indicating that the 
biosensor is more active at this pH range and the immobilized enzymes retain their natural 
structure and do not denature. Thus, all the performance tests of the biosensor were conducted at 
pH 7.4 to simulate the physiological condition.  
Figure 5.4A presents the two CV curves of the Ti/NPAu/ChOx-HRP-ChE electrode 
recorded in a phosphate buffer solution (pH 7.4) in the absence of cholesterol (dashed line) and 
in the presence of 300 mg.dl-1 cholesterol (solid line). Comparison of the two CV curves shows 
that the addition of cholesterol decreased the anodic current and significantly increased the 
cathodic current, revealing the strong response of the Ti/AuNPs/ChOx-HRP-ChE electrode to 
cholesterol.  As seen in Figure 5.4B, the reduction peak current increased strongly with the 
increase of the concentration of cholesterol, illustrating a typical electrocatalytic reduction 
process of H2O2 produced by the enzymatic reaction of cholesterol with cholesterol oxidase on 
the biosensor surface area as the following mechanism:26 
Cholesterol + O2  →   Cholest-4-en-3-one + H2O2                    (1) 
            Cholesterol ester + H2O → Cholesterol + Fatty acids              (1*) 
Cholesterol oxidase is an alcohol dehydrogenase/oxidase flavoprotein that catalyzes the 
dehydrogenation of C(3)-OH of a cholesterol molecule to yield the corresponding carbonyl 
ChOx 
ChE 
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product. During the reductive half-reaction, the oxidized FAD (flavin adenine dinucleotide) 
cofactor accepts a hydride from the substrate and, in the ensuing oxidative half-reaction, the 
reduced flavin transfers the redox equivalents to molecular oxygen yielding hydrogen peroxide. 
Interestingly, the carbonyl species can also catalyze the isomerization of cholest-5-en-3-one (the 
product of the redox reaction) to cholest-4-en-3-one 26. While the immobilized ChOx catalyzes 
the oxidation of cholesterol, the ChE catalyzes the hydrolysis of esterase-esterified cholesterol, 
thus allowing us to determine the total cholesterol. 
 To sense the formed H2O2 in Equation 1 electrochemically, either a reducing or oxidising 
agent is required. Peroxidases such as HRP are ubiquitous oxidative heme-containing enzymes 
with which, in an early step in the catalytic cycle, H2O2 binds to the heme in the Fe(III) state. 
This binding causes the heterolytic cleavage of the oxygen-oxygen bond of H2O2.
27 
H2O2 + HRP(Fe(III)) → Compound I(Fe(IV)=O) + H2O                  (2) 
Compound I(Fe(IV)=O) → Compound II(Fe(IV)=O)                       (3) 
Compound II(Fe(IV)=O) → HRP(Fe(III)) + H2O                              (4) 
 A water molecule is released during this reaction with the concomitant two-electron 
oxidation of the heme to form an intermediate (compound I) comprising a ferryl species 
(Fe(IV)=O) and a porphyrin radical cation.28 Compound I is then converted back to the resting 
enzyme via two successive single-electron transfers from the reducing substrate molecules. The 
first reduction of the porphyrin radical cation yields a second enzyme intermediate, compound II,  
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Figure 5.4. (A) Cyclic voltammetric response of the Ti/AuNPs/ChOx-HRP-ChE electrode 
measured  a phosphate buffer (pH 7.4) in the absence (dashed line) and presence (solid line) of 
cholesterol 300mg.dl-1, (B and C) Cyclic voltammograms and calibration curve of the biosensor 
upon addition of different concentrations of cholesterol in phosphate buffer (pH 7.4). Potehtial 
scan rate: 50 mV s-1.  
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which retains the heme in the ferryl (Fe(IV)=O) state.29 Compound II oxidizes an additional 
equivalent of substrate, generating ferric enzyme and the corresponding substrate free radical.8 
 As seen in Figure 5.4C, the cyclic voltammetric response of the Ti/NPAu/ChOx-HRP-ChE 
biosensor to different concentrations of cholesterol solutions shows a linear dynamic range of up 
to 300 mg.dl-1 and sensitivity of 29.33 µA.mM-1.cm-2. Five biosensors constructed independently 
gave a relative standard deviation (R.S.D.) of 5.0%. The limit of detection of the biosensor was 
calculated to be 1 mg.dl-1. Since the desired total plasma cholesterol for an individual is less than 
5.2 mM (200 mg.dl-1), with a high level being considered as greater than 6.2mM (240 mg.dl-1), 
the fabricated biosensor covers a wide range of cholesterol concentration, promising for the 
clinical diagnostics of total cholesterol. 
The apparent Michaelis-Menten constant (  
   ), which gives an indication of the enzyme–
substrate kinetics, can be estimated from the Lineweaver–Burk equation:30 
 1/Iss = (  
   /Imax) (1/C) + 1/Imax                                                  (5) 
where Iss is the steady state current, Imax is the current measured for the enzymatic product when 
electrode surface is saturated and C is the concentration of cholesterol. From the Lineweaver–
Burk equation, the apparent Michaelis-Menten constant of the Ti/NPAu/ChOx-HRP-ChE 
biosensor was calculated to be 0.64 mM, which is much lower than the cholesterol biosensors 
reported in literature (Table 5.1). The small   
    value indicates that the immobilized enzymes 
possess high enzymatic activity and that the fabricated biosensor exhibits a high affinity for 
cholesterol. 
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Table 5.1 Comparison of the performances of various types of gold-based cholesterol 
biosensors. 
ChOx: Cholesterol oxidase, ChEt & ChE: Cholesterol esterase, DTSP: dithiobissuccinimidyl 
propionate, Au: Gold, MWNT: Multi-wall carbon nanotubes, Chi: Chitosan, IL: Ionic liquid, 
NPAu: Nanoporous gold, HRP: Horseradish peroxidase , PPD: poly(o-phenylenediamine) 
 
 
5.3.3. Selectivity and long-term stability of the biosensor 
We further tested the selectivity of the Ti/NPAu/ChOx-HRP-ChE biosensor using four 
common interfering species. Figure 5.5 presents the response of the Ti/NPAu/ChOx-HRP-ChE 
biosensor to 0.1mM ascorbic acid, 5mM lactic acid, 5mM glucose, 0.1mM uric acid and 5.2mM 
cholesterol in 0.1 M PBS (pH 7.4). The biosensor produces negligible current signals for lactic 
acid and uric acid, a small response to ascorbic acid and glucose, but a very strong response to 
cholesterol. 
 
Electrode Km 
mM 
Sensitivity 
µA mM-1 
Linearity 
mM 
Durability 
DTSP-Au/ChOx
31 N/A 0.054 0.2 -2.1 40 days, 77% 
(MWNTs)-Au/PPD-ChOx
32 7.17 0.559 0.5-6 N/A 
MWNT(SH)–Au/Chi–IL/ChOx
14 N/A 0.2 0.5-5 20 days, 80% 
Au Nanowire/ChOx-ChE26 17.1 0.85 0.01-0.060 10 days, 75% 
This work 0.64 29.33 0.97-7.8 60 days, 95% 
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Figure 5.5. Selectivity response of the Ti/NPAu/ChOx-HRP-ChE electrode after the addition of 
ascorbic acid (0.1 mM), lactic acid (5 mM) , glucose (5 mM), uric acid (0.1 mM) and finally 
cholesterol (5.2 mM) into phosphate buffer (pH 7.4) individually (background current was 
subtracted). 
 
The stability of the Ti/NPAu/ChOx-HRP-ChE biosensor was tested by measurement of a 
200 mg dl−1 standard cholesterol solution for 60 days. The tests were carried out once a week. 
During this period, the biosensors were stored in a phosphate buffer solution at 4ºC. The 
biosensor exhibited 95% of the initial current response after the 60-day period. The high stability 
can be attributed to the use of chitosan and the nanoporous Au networks. Since chitosan in an 
aqueous solvent is protonated and positively charged, it can be strongly adsorbed onto the 
nanoporous gold networks. The resulting interaction between gold-chitosan increases the 
retention of enzymes on the surface. In addition, gold nanostructures can strongly adsorb 
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enzymes and prevent the leakage of the immobilized enzymes 33.  The high sensitivity and high 
stability of the fabricated biosensor indicate that the nanoporous Au network structure along with 
chitosan provides an excellent microenvironment for the immobilization of the enzymes. 
5.3.4. Real Sample Analysis 
The developed Ti/NPAu/ChOx-HRP-ChE biosensor was further tested using real food 
samples butter, margarine and fish oil. The real samples were prepared using the same procedure 
as the cholesterol standard solution.  The Margarine sample, which contains only vegetable fat, 
showed a small signal.  
As seen in Table 5.2, the amount of total cholesterol found in butter, margarine and fish oil 
was 2.35, 0.69 and 45.82 mg, respectively. This is in good agreement with the amount of the 
total cholesterol listed on the product labels (2.4, 0 and 46 mg for Organic butter, NoName 
margarine and Naturaceutical Science Institute fish oil, respectively). 
Table 5.2 Cholesterol detection of real samples by the Ti/AuNPs/ChOx-HRP-ChE biosensor. 
Samples 
AuNPs biosensor 
 (mg) 
Product label 
(mg) 
Brand 
Margarine 0.69 ±0.05 0 NoName 
Organic Butter 2.35±0.03 2.4 Harmonie 
Fish oil 45.82±0.06 46 Naturaceutical Science Institute 
All these results show that the fabricated cholesterol biosensor offers a great potential of 
application in cholesterol quality control of food products. 
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5.4. Conclusions 
We have successfully fabricated a novel high-performance cholesterol biosensor by co-
immobilizing cholesterol oxidase, cholesterol esterase and horseradish peroxidase on the 
nanoporous gold networks. The immobilized cholesterol oxidase effectively catalyzes the 
oxidation of cholesterol while the cholesterol esterase catalyzes the hydrolysis of esterase-
esterified cholesterol, thus allowing the determination of the total cholesterol. Meanwhile, the 
immobilized horseradish peroxidase facilitates the detection of the H2O2 generated by the 
catalytic conversion of cholesterol to cholest-4-en-3-one. The developed Ti/NPAu/ChOx-HRP-
ChE biosensor showed highly anti-interferents behaviour as tested toward common interfering 
species such as ascorbic acid, uric acid, lactic acid and glucose. A very low Michaelis-Menten 
constant indicates a very high activity of the immobilized enzymes. Under the physiological 
condition (pH 7.4), the designed biosensor exhibited reliable cyclic voltammetric responses, high 
sensitivity, a wide linear range up to 300 mg.dl-1 and very high stability. The developed 
biosensor was also successfully used to measure the total cholesterol in real food samples. The 
high-performance along with the ease of fabrication and low costs makes the new 
Ti/NPAu/ChOx-HRP-ChE biosensor promising for the detection of total cholesterol in both 
clinical diagnostics and the food industry. 
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Chapter 6 
Mediator-Free Electrochemical Biosensor Based on Buckypaper 
with Enhanced Stability and Sensitivity for Glucose Detection* 
6.1. Intuduction 
Buckypapers are thin membranes (10-50 µm) of carbon nanotube (CNT) networks which 
are classified as smart nanomaterials owing to their remarkable structural, mechanical, 
electrochemical, piezoresistive and physical properties.1 Since the discovery of CNTs in 1991,2 
tremendous efforts have been made to modify the characteristics of CNTs both chemically3-6 and 
physically7 toward the development of thin films of CNTs.  Among the two types of CNTs, 
single-wall carbon nanotubes (SWNTs) and multi-wall carbon nanotubes (MWNTs), SWNTs 
consist of a single fullerene-structured graphite sheet, which is rolled seamlessly to form a 
nanotube.2  SWNTs have a strong tendency to form bundles and aggregate due to their inherently 
high surface areas and strong Van der Waals interactions. In addition, SWNT networks exhibit 
higher conductivity than MWNTs.8 In addition, mechanical deformation and chemical 
functionalization can improve  interconnectivity of CNTs.4 In this regard, polymerization has 
been widely used in the synthesis of homogenous and compressed CNT films.9-10 Park et al. 
attempted an in situ polymerization method with the aim of dispersing as-pristine SWNT bundles 
into polyimide with the aid of sonication.11 Two challenges were encountered: the dispersion 
issue and the rapidly increasing viscosity of the polymer. This chemical modification may also 
destroy the pristine structure of the SWNTs, resulting in a decrease of the maximum modulus 
                                                 
* Most of the results presented in this chapter have been published in Biosensors and 
Bioelectronics, 2011, 30, 287. 
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and strength by 15% .12 Hence, to adapt CNT powder in the formation of substrates for certain 
applications such as biosensors, a variety of conductive supporting chemical matrices have been 
explored.13-22 Another approach was the introduction of functionalities such as carboxylic groups 
into the side walls of CNTs. For most of the aforementioned CNT-based sensors, glassy carbon 
was used as a conductive substrate; however, the fabrication suffered from the necessity of 
complex reagents, homogeneity and a multiple step preparation process which, in turn, lowered 
the activity and stability of the resulting sensors. 
It has been reported that CNTs in conjunction with a mediator or at a fairly high operating 
electrode potential have an enhanced effect on the electrocatalytic activity of glucose oxidase 
(GOx) for the oxidation of glucose.
14-15, 23-26 However, mediated biosensors are subjected to a low 
selectivity and high toxicity. These drawbacks limit their in vivo applications. On the other hand, 
at a high potential, common electroactive species such as ascorbic acid, uric acid and 
acetamidophenol may act as interfering agents. Several strategies have been employed to 
minimize the effects of this interference. Polymeric membranes and metal-based compounds 
have been utilized.17, 27-30 Effective but nonsufficient rejection of interferents has been reported 
in most cases. Moreover, multiple preparation steps and manipulation lower the sensor activity 
and increase its complexity. Such detection relies on the tuning of the operating potential to the 
optimal region of 0.0 to -0.20 V vs Ag/AgCl to effectively detect hydrogen peroxide released 
from the reaction of GOx and glucose using peroxidases.
27 Although a few mediator-free bi-
enzyme glucose sensors based on CNTs have been reported in the literature,31-34 the narrow 
linear dynamic range, low sensitivity and stability hamper their medical diagnostic application. 
In this study, we have designed a mediator-free glucose sensor based on buckypaper. To 
the best of our knowledge, this is the first time that titanium interfaced buckypaper has been 
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explored in the design of an electrochemical biosensor. The glucose sensor fabricated with the 
scheme proposed in this study exhibited high sensitivity, stability, selectivity and reproducibility. 
The robust buckypaper-based platform presented in this study is anticipated to open the door for 
the design of high-performance electrochemical biosensors for medical diagnostics and 
environmental monitoring. 
6.2. Experimental 
6.2.1. Materials  
The buckypaper used in this study was produced by the High-Performance Materials 
Institute of Florida State University with a thickness of 0.035 mm. Glucose oxidase (EC 1.1.3.4, 
Type VII from Aspergillus niger) and β-D-glucose were purchased from Sigma and were used as 
received. Chitosan was purchased from Aldrich and titanium foils (99.2%) from Alfa Aesar. 
Horseradish peroxidase (HRP), potassium ferricyanide (K3Fe(CN)6), ascorbic acid, uric acid, 3-
acetamidophenol were purchased from Sigma–Aldrich. All other reagents were of analytical 
grade. Water was puriﬁed with the Nanopure® water system (18 MΩ.cm) and was used in the 
preparation of all solutions. Various stock concentrations of β-D-glucose were prepared in 0.1 M 
phosphate buffer, pH 7.4 and stored at 4 ºC. Glucose stock solutions were allowed to mutarotate 
overnight prior to use. 
6.2.2. Instrumentation and electrochemical measurements  
Field-emission scanning electron microscopy (FE-SEM) (Hitachi, SU-4800), transmission 
electron microscopy (TEM) (JOEL 2010F) and energy dispersive x-ray spectrometry (EDS) 
were utilized to characterize the morphology and composition of the buckypaper. FTIR spectra 
were recorded using a NICOLET 8700 FTIR (Thermo Scientific, USA). Cyclic voltammetry 
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(CV) and amperometric measurements were performed using an electrochemical workstation 
(CHI660, CH Instrument Inc., USA) connected with an in-house-built, three-electrode glass cell 
(30 mL). A platinum coil was used as a counter electrode and was flame-annealed prior to each 
experiment. Ag/AgCl (3 M KCl) was used as a reference electrode. The constructed hybrid 
titanium/buckypaper-based biosensors were employed as working electrodes. All measurements 
were conducted at room temperature (22 ± 2 °C).  
6.2.3. Biosensor preparation  
The detailed procedure of the biosensor fabrication is illustrated in Scheme 6.1.   
 
Scheme 6.1. Schematic diagram for the preparation of the buckypaper-based electrochemical 
biosensor. (a) a titanium plate sputtered with a thin layer of gold; (b) gold interaction with 
chitosan; (c) attachment of buckypaper to the gold surface by chitosan; (d) activation of 
buckypaper ; (e) immobilization of enzymes; (f) the fabricated biosensor. 
 
Titanium plates (1.25 cm × 0.8 cm × 0.5 mm) were ultrasonically cleaned in acetone, 
ethanol and water. To provide a mechanical support for the buckypaper and to enhance the 
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conductivity, a titanium plate was coated with an Au thin film sputtered by argon plasma for 30 s 
(Scheme 6.1a). After rinsing with pure water, a section of buckypaper was attached to the gold 
coated titanium plate with the aid of 5µL of 2 mg.mL-1 chitosan (Scheme 6.1b & c).  
In order to engender this structure with utility as a glucose biosensor, the buckypaper was 
electrochemically activated.  To activate the buckypaper (BP) surface, cyclic voltammetry was 
performed in the range of -0.8 to 0.4 V at a scan rate of 10 mV.s-1 in phosphate buffer solution 
(PBS) at pH 7.4 until a steady cyclic voltammogram was obtained, and then a potential of 1.5 V 
was applied for 90 s. This step led to the functionalization of the buckypaper with carboxlic 
groups (Scheme 6.1d). The activated surface was thus ready for the immobilization of enzymes. 
To immobilize the enzymes, a mixed solution of 20 µL of 5 mg.mL-1 GOx, 10 µL of 2 mg.mL
-1 
HRP and 10 µL of 2 mg.mL-1 chitosan was cast onto the buckypaper (Scheme 6.1e and f). All 
prepared biosensors (Ti/Au/BP/GOx-HRP) were stored at 4 ºC in 0.1 M PBS at pH 7.4 when not 
in use. 
6.3. Results and discussion 
6.3.1. Surface morphological studies 
The morphology and composition of the buckypaper were characterized using FESEM, 
TEM and EDS.  Figure 6.1A shows a photograph of the buckypaper used in this study. It is a 
very thin film. A typical FESEM image is presented in Figure 6.1B, which reveals that the 
SWNTs were arranged in bundles, forming networks. A high magnification TEM image of the 
buckypaper is displayed in Figure 6.2A, showing that the nanotubes were aggregated in a rope 
structure; the diameter of an individual SWNT was less than 4 nm. The volume density of 
buckypaper represents a high specific surface area, desirable for the immobilization of enzymes. 
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Figure 6.2B shows the EDS spectrum of the buckypaper. Only carbon and oxygen peaks were 
observed with no other discernable peaks, indicating the absence of impurities such as heavy 
metals. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.1. (a) A photograph; (b) FESEM image of the buckypaper 
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Figure 6.2. (A) TEM image; and (B) the corresponding EDS spectrum of the buckypaper. 
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6.3.2. Electrochemical characterization 
The cyclic voltammograms of the Ti/BP, Ti/Au/BP, and Ti/Au/BP/GOx-HRP electrodes 
recorded in 0.1M K3Fe(CN)6 + 0.1M KCl + 0.1M PBS (pH 7.4) at a scan rate of 50 mV.s
-1 are 
presented in Figure 6.3. The well-defined oxidation and reduction peaks are observable due to 
the Fe3+/Fe2+ redox couple. In the absence of the Au thin film, the oxidation peak appeared at 
0.46V, while the reduction peak was observed at around -0.36V vs Ag/AgCl. The peak-to-peak 
separation (ΔEp) was 0.82V for the Ti/BP electrode. While in the presence of the sputtered Au 
thin film (Ti/Au/BP electrode), ΔEp decreases to 0.47V. In addition, the peak current increased 
by approximately 40%. All these results show that the sputtered gold thin film significantly 
enhanced the electrical communication between the buckyppaer and the titanium substrate. After 
the immobilization of the enzymes GOx and HRP, both ΔEp and peak current (Ip) slightly 
decreased. The electrochemical active surface area of the Ti/Au/BP and Ti/Au/BP/GOx-HRP 
electrodes may be calculated via the Randles-Sevcik equation:35 
Ip=2.69×10
5AD1/2n3/2υ1/2C 
where n is the number of electrons that participate in the redox reaction, A is the area of the 
electrode (cm2), D is the diffusion coefficient of the probe molecule in the bulk solution (cm2.s-
1), C is the concentration of the K3Fe(CN)6 in the bulk solution (mol.cm
-3) , and υ is the scan rate 
(V.s-1). The electroactive surface area of the Ti/Au/BP and Ti/Au/BP/GOx-HRP electrodes is 
thus estimated to be 1.85 and 1.75 cm2, respectively. The slightly decrease in the electroactive 
surface area subsequent to the immobilization of the enzymes can be attributed to the blockage 
of some redox sites by GOx and HRP, indicating that the immobilization did not diminish 
electron transfer between the redox species and the electrode substrate.  
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To investigate whether GOx immobilized on the activated buckypaper retains its bio-
electrocatalytic activity for the oxidation of glucose, control experiments were conducted for the 
Ti/Au/PB, Ti/Au/PB/HRP and Ti/Au/BP/HRP-GOx electrodes.  
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Figure 6.3. Cyclic voltammograms of Ti/BP (a), Ti/Au/BP (b), and Ti/Au/BP/GOx-HRP (c) 
electrodes at a scan rate of 50 mV.s-1 in 0.1 M K3Fe(CN)6 + 0.1 M KCl + 0.1 M PBS solution pH 
7.4. 
 
As seen in the CV curves (Figure 6.4) recorded in 0.1 M PBS (pH 7.4), a pair of well-
defined peaks centered at -0.19 and -0.5 V were observed for the Ti/Au/PB electrode, which can 
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be attributed to the surface functionalities of the activated buckypaper. The well-defined peaks 
disappeared after the immobilization of HRP with the aid of chitosan due to the interactions 
between the functional groups of the activated buckypaper with chitosan. In contrast, a pair of 
well-defined redox peaks located at -0.09 and -0.35 V appeared after the co-immobilization of 
HRP and GOx with the aid of chitosan, showing the direct electrochemistry of the GOx 
immobilized on the buckypaper. 
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Figure 6.4. Cyclic voltammograms of Ti/Au/BP (a), Ti/Au/BP/HRP (b), and Ti/Au/BP/GOx-
HRP (c) electrodes in PBS pH 7.4. 
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Figure 6.5. Cyclic voltammograms of Ti/Au/BP/GOx-HRP electrode before (a) and after (b) 
injection of 10 mM glucose at the scan rate of 10 mV.s-1 in  PBS pH 7.4. 
 
The formal potential, E0=1/2 (Epa + Epc), was calculated to be -0.22V. This indicates that the 
activated buckypaper improves the contact between the electrode surface and GOx and decreases 
the overpotential required for the FAD/FADH2 redox reaction.
36 The effect of the scan rate on 
the cyclic voltammograms of the Ti/Au/BP/GOx-HRP electrode was studied in the range of 5 to 
50 mV.s-1 in 0.1M PBS.  A pair of symmetric and well-defined redox peaks were obtained with a 
linear relationship between the current and scan rate, indicating that the redox process of the 
immobilized GOx is a surface-controlled redox reaction rather than diffusion-controlled reaction. 
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The amount of the electroactive enzymes, Γ =Q/nFA, (where Q is the charge, n is the 
electron transfer number, F is the faraday constant, and A is the geometric area of the working 
electrode) was calculated to be 3.65×10-9 mol.cm-2. This value is much higher than the 
theoretical value for a monolayer of GOx (2.86×10
−12 mol cm−2)37 and a monolayer of HRP 
(8.5×10−12 mol cm-2)38 and experimental values (7.52×10-10 mol cm−2 for GOx  and 2.1×10−11 
mol cm−2 for HRP) reported  in the literature,16, 39-41 indicating that the enzymes immobilized on 
the buckypaper effectively participated in the electron transfer.  
 We further studied the response of the Ti/Au/BP/GOx-HRP electrode to glucose. As 
shown in Figure 6.5, upon addition of 10mM glucose, the oxidation peak current decreased while 
the reduction current significantly increased, showing a strong response to glucose. This can be 
attributed to the reduction of H2O2 generated by the oxidation of glucose by the immobilized 
GOx as per the following equations:
15, 42-43  
   β-D-glucose +  GOx-FAD → δ-D-gluconolactone + GOx-FADH2                  (1) 
   GOx-FADH2 + O2 → GOx-FAD + H2O2        (2) 
   HRP(Fe3+) + H2O2 → CompoundI(Fe
4+ = O) + H2O              (3) 
   CompoundI(Fe4+ = O) + e− + H+→ CompoundII                                               (4) 
   CompoundII + e− + H+ → HRP(Fe3+) + H2O                                                     (5) 
GOx, as a glycoprotein, oxidizes glucose to gluconolactone and hydrogen peroxide in the 
presence of oxygen. On the other hand, HRP, as an oxidative heme-containing enzyme, cleaves 
the O-O bond of hydrogen peroxide. Compound I is an intermediate comprising a ferryl species 
and a porphyrin radical cation; while Compound II is the second intermediate from the first 
reduction of the porphyrin radical cation, which retains the heme in the ferryl state.  
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Figure 6.6 Amperometric response of the Ti/Au/BP/GOx-HRP electrode upon addition of 1mM 
glucose at different potentials (A), and the corresponding current change for 4mM glucose (B) in 
PBS at pH 7.4. 
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To achieve a maximum current response, the detection of glucose under optimized 
applied potential is necessary. Figure 6.6A shows the responses of the Ti/Au/BP/GOx-HRP 
biosensor upon the successive addition of 2 mM glucose at different potentials. At 0.1V a small 
current response was observed. The cathodic current response to glucose significantly increased 
when the potential was lowered to -0.1V. By further lowering the electrode potential to -0.2 or -
0.3 V, the current response decreased. Figure 6.6B compares the corresponding current response 
to 4mM glucose at different potentials, showing that -0.1V is the optimum potential for the 
Ti/Au/BP/GOx-HRP biosensor.   
The amperometric response of the Ti/Au/BP/GOx-HRP biosensor at the optimized 
potential under the physiological pH 7.4 upon the successive addition of 1 mM glucose is shown 
in Figure 6.7A. For comparison, the amperometric response of the Ti/Au/BP electrode is also 
included in Figure 6.7A. No obvious current response was observed at the non-enzymatic 
electrode, while a strong response was achieved by the enzymatic electrode. Figure 6.7B shows 
the corresponding current vs. glucose concentration plot for the biosensor. A linear relationship 
with a correlation coefficient R2 of 0.993 was obtained in the glucose range of over 9 mM, which 
effectively covers the normal physiological glucose range (3-7 mM). The sensitivity and the 
detection limit of the fabricated biosensor are thus estimated to be 20 µA.mM-1.cm-2 and 0.01 
mM, respectively. 
To examine the ability of the biosensor to detect low concentrations of glucose, the 
amperometric study was further conducted with the injection of 0.25 mM glucose under the same 
experimental conditions. As shown in Figure 6.8A, a strong response to each injection was 
observed. 
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Figure 6.7. Amperometric response and calibration curve of the Ti/Au/BP/GOx-HRP (i) and 
Ti/Au/BP (ii) electrodes upon addition of 1 mM glucose (A and B). 
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Figure 6.8. Amperometric response and calibration curve of the Ti/Au/BP/GOx-HRP upon 
addition of 0.25 mM (C and D) at -0.1V in PBS pH 7.4. 
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A linear relationship with a correlation coefficient R2 of 0.993 (Figure 6.8B) was 
obtained in the range of 0-0.75 mM glucose. The calculated sensitivity is as high as the one 
determined from Figure 6.7B for the 1 mM successive injection, further showing that the 
biosensor is very sensitive to glucose.  
To evaluate the efficiency of the immobilized enzymes, the apparent Michaelis-Menten 
constant,  can be determined using the following “Lineweaver-Burk” type equation: 
1/Iss = ( /Imax) (1/C) + 1/Imax 
where Imax and Iss are the currents measured for enzymatic product detection under conditions of 
substrate saturation and steady state, respectively, for a given substrate concentration C.44-45 This 
equation allows us to plot the experimental Imax/Is vs. 1/C to determine  from the slope of 
the resultant linear plot. The value of was obtained to be 4.67 mM for the fabricated 
biosensor. This low value reflects the efficient enzyme immobilization process proposed in 
this study.  
6.3.3. Selectivity of the biosensor 
To investigate the selectivity of the Ti/Au/BP/GOx-HRP biosensor, we tested its response to the 
common interfering species including ascorbic acid (AA), uric acid (UA) and acetamidophenol 
(AP). 
As shown in Figure 6.9, there is no salient current response upon the addition of the interferents 
at their physiological level, 0.1 mM AA, 0.1 mM UA and 0.1 mM AP. In contrast, a strong 
response to the successive injection of 1 mM glucose was observed in the presence of all the 
three common interfering species, showing that the Ti/Au/BP/GOx-HRP biosensor allows for the 
highly selective quantiﬁcation of glucose without the usage of membranes or metal particles. 
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6.3.4. Stability of the biosensor 
 The stability of the fabricated biosensor was further investigated. The biosensor was 
tested once a week in a stirring cell during the electrochemical measurements.  It was stored in 
0.1 M PBS (pH 7.4) at 4 ºC when not in use. Figure 6.10A presents the amperometric response 
of the Ti/Au/BP/GOx-HRP biosensor at the beginning (red line) and after 80 days (black line) 
upon addition of 1.2 mM glucose at -0.1 V in 0.1 M PBS (pH 7.4), revealing that the biosensor 
retained 94% of its initial current response after such a long period of time. 
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Figure 6.9. Amperometric response of the Ti/Au/BP/GOx-HRP electrode upon successive 
addition of 1mM glucose in the presence of interferents AA (ascorbic acid), UA (uric acid), AP 
(3-Acetamidopheol) at -0.1 V in PBS pH 7.4. 
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Figure 6.10. (A) Amperometric response of the Ti/Au/BP/GOx-HRP electrode initially (red line) 
and after a period of 80 days (black line) upon addition of 1.2 mM glucose at -0.1 V in PBS pH 
7.4. (B) Comparison of the current response of the Ti/Au/BP/GOx-HRP electrode to 1.2 mM 
glucose during the 80-day stability tests.      
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Three biosensors were prepared and tested for their stability. Figure 6.10B presents the 
amperometric response of the biosensors versus time. The relative standard deviation (RSD) of 
their response to glucose was 3.0%. Over 98% of their initial current response was retained 
during the first 50 days. The reproducibility of the biosensor for the current response was also 
tested, showing that the RSD was 3.5% for 10 successive measurements of 1mM glucose at -
0.1V in 0.1M PBS (pH 7.4).  
We further compared the performance of the biosensor developed in this study with that of 
the various CNT-based glucose biosensors reported in the literature. As seen in Table 6.1, the 
mediator-free biosensor developed in this study possesses remarkable properties in terms of 
linear dynamic range and stability compared to the other mediator-based and mediator-less 
biosensors. During the 80-day stability tests, the biosensors were washed each time and the 
temperature was changed regularly between 4 oC and room temperature. The long lifetime shows 
that the Ti/Au/BP/GOx-HRP biosensor fabricated by the innovative procedure proposed in this 
study possesses high thermal stability and excellent mechanical strength. This can be attributed 
to the efficient immobilization of the enzymes along with the unique physical and chemical 
properties of the activated buckypaper. The interaction between the Au thin film sputtered on the 
Ti substrate and the buckypaper with the aid of chitosan is so strong that it is almost impossible 
to remove the buckypaper from the substrate without breaking the buckypaper film. Chitosan 
contains primary amines, hydroxyl and acetyl groups which under weakly acidic conditions are 
protonated. These charged functional groups on chitosan molecules might induce strong 
adsorption of chitosan onto the surface of Au in the way similar to the modification of Au 
surface with charged alkanethiols.46 To decipher the significant role of the activated buckypaper 
in the fabrication of the biosensor with high stability, we carried out FTIR analysis. Figure 6.11  
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Table 6.1 Comparison of the performance of different carbon nanotube-based glucose 
biosensors. 
Electrode modifier Detection 
Limit (µM) 
Linear Range 
(mM) 
Stability 
% (day) 
Detection 
Potential (V) 
(Au-Pt)NPs/CNT/Au/GOx18 400 0.5-17.5 75 (25) 0.6 
GCE/PB/MWNT/GOx25 12.7 0.0-8.0 85 (14) 0.0 
GCE/CNT-PtNPs/GOx6 0.5 0.5 ×10-3-5.0 N/A 0.55 
PDDA/GOx/PDDA/CNT/GCE49 7.0 15×10-3-6.0 90 (30) -0.1 
MWNT/Nafion/GCE/GOx17 4.0 25×10-3-2 N/A 0.7 
GCE/CNT-CHIT-GDI-GDH50 3.0 5×10-3-0.3×10-3 80 (4) 0.4 
SWNTs/Nafion/GCE/FMCA24 6.0 0.0-6.0 N/A 0.3 
GC/CNT/HRP-GOx/Nafion31 0.5 0.025-0.4 97 (7) 0.0 
Au/SWNT/GOD-HRP/PPy32 90 0.030-2.43 67 (14) -0.1 
HRP-GOxCNT/PAMAM33 2.5 0.004-1.2 N/A -0.34 
GOD–HRP–Cys–SG/GNP/ITO34 10 0.02-3.2 80 (5) -0.1 
Proposed biosensor 10 0.0-9.0 94 (>80) -0.1 
GCE: glassy carbon electrode, GOx: glucose oxidase, MWNTs: multi-walled carbon nanotubes, 
PB: Prussian blue, PDDA:  polydiallyldimethylammonium chloride, SWNTs: single-walled 
carbon nanotubes, Au: gold, PtNPs: Platinum nanoparticles, CNT: carbon nanotubes, CHIT: 
chitosan, GDI: glutaric dialdehyde, GDH: glucose dehy-drogenase; FMCA: ferrocene 
monocarboxylic acid; PPy: polypyrrole; PAMAM: poly(amidoamine); Cys: L-Cysteine; SG: sol-
gel; ITO: indium tin oxide;  N/A: not available. 
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presents the FTIR spectra of the activated buckypaper (a), chitosan immobilized on the activated 
buckypaper (b), and chitosan (c). For the activated buckypaper (Figure 6.11a), several strong 
peaks were observed. The peaks located at 1719 and 1652 cm-1 can be assigned to the C=O 
stretching vibration of -COOH and -COO- groups, respectively, which were generated during the 
electrochemical treatment. The peaks at 1597, 1505 and 1448 cm-1 could be attributed to the 
C=C aromatic vibrational modes of the SWNTs in accordance with previous reports.23, 47-48 
Wavenumber (cm-1)
100012001400160018002000
A
bs
or
ba
nc
e
c
b
a
17
19
16
42
89
2
11
50
1638
0.
05
15
97
15
05
14
48
15
49
15
49 14
04
10
2210
62
14
04
12
76
13
16
12
63
11
27
 
Figure 6.11. FT-IR spectra of activated buckypaper (a), chitosan on the activated buckypaper 
(b), and chitosan (c). 
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The FTIR spectrum of chitosan (Figure 6.11c) contains the C-N stretching at 1404 cm-1 and NH2 
bending vibration modes at ~1549 and 1638 cm-1. The upshift in this region observed in the 
spectrum of the chitosan-buckypaper indicates a strong interaction between the –COOH and –
NH2 groups and the formation of –NHCO- (Figure 6.11b). The very strong peaks at 1022 and 
1062 cm-1 are the typical stretching vibration of the C-O bond. The peak at 1638 cm-1 in the 
spectrum of chitosan which can be related to the N-H of amide (I) group, almost disappeared in 
the spectrum of chitosan-buckypaper. The spectrum of the activated buckypaper shows strong 
peaks at 1200 and 1263 cm-1 which can be attributed to C-O aliphatic group and C-O of 
carboxylic acids, respectively. These two peaks also disappeared in the spectrum of chitosan-
buckypaper.  Two bands of the glucopyranose rings appeared at ca. 892 and 1150 cm-1, implying 
the attachment of chitosan to the activated buckypaper. These results confirm the 
functionalization of the buckypaper with chitosan, which has strong interactions with 
nucleophilic substitutions by primary and secondary amines that exist in abundance on the 
surface of the glycoprotein. Therefore, the interconnectivity of physically aggregated CNTs in 
the buckypaper, its compatibility and strong interactions with chitosan on one hand and chitosan 
interaction with the enzymes on the other hand may significantly enhance the interfacial 
adhesion and mechanical strength of the biosensor. 
6.4. Conclusion 
In summary, we have fabricated a mediator-free glucose biosensor based on the co-
immobilization of GOx and HRP on the activated buckypaper. Direct electrochemistry of GOx on 
the buckypaper was observed. The glucose biosensor showed a high sensitivity, low detection 
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limit (0.01mM), fairly wide linear dynamic range (0-9 mM), long life-time (over 80 days) and 
high selectivity in the presence of common interferent species under the physiological condition. 
These properties of the buckypaper-based biosensor, coupled with the biocompatibility of its 
components are important factors which could be attractive for real-time in vivo glucose 
monitoring and lead to a substantial improvement in the management of diabetes. The facile and 
robust buckypaper-based platform proposed in this study opens many opportunities for the 
development of high-performance electrochemical biosensors for medical diagnostics and 
environmental monitoring. 
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Chapter 7 
Controllable Growth of Titanium Dioxide Nanowire and its Size 
Effect on Electrochemical Biosensing* 
7.1. Introduction 
Over the past few decades, the development of bioactive and biocompatible materials has 
attracted much interest for a variety of prospective technological applications encompassing 
sensors,1-3 drug delivery,4 and chromatographic supports.5 Such efforts aim to achieve 
miniaturized and cost effective devices with enhanced sensitivity and recognition limits for the 
detection of biomolecules. Proteins, as bio-recognition elements, are potentially capable of 
interacting with specific biomolecules and differentiating them electrochemically, while redox-
active sites of proteins encounter an intrinsic barrier to direct electron transfer. This barrier 
emerges from the spatial configuration of protein components that surround and insulate the 
redox center.6-7 Accordingly, various innovative strategies have been proposed and investigated 
with the aim of enabling electron transfer at the redox centers of proteins. Among them, the 
chemical modification of proteins,8 protein wiring,9-10 artificial mediators,11-12 and 
nanostructured materials13-15 have been extensively studied.  
In the development of biosensors, nanostructure materials are particularly attractive due to 
their intrinsically high surface area, intimate and specific attachment of protein, and 
biocompatibility.16-17 These biophysical attributes are likely to be contingent on the size, 
geometries, and composition of the nanostructures. The concept of utilizing inorganic, receptor 
                                                          
*Most of the results presented in this chapter have been submitted to a Peer-Reviewed Journal. 
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or ligand-modified nanowires and nanotubes for specific detection has been extended in various 
directions such as the real-time monitoring of biological and chemical species.1, 3, 18 Inorganic 
nanotubes and nanowires may typically be prepared using two approaches: namely “top-down” 
and “bottom-up”. It is desirable to precisely control the sizes and shapes of formed 
nanomaterials; however, it is often a challenge to achieve.  
Among all inorganic nanomaterials, titanium dioxide (TiO2), as a transition-metal oxide, 
has been extensively studied.19-20 Exceptional biocompatibility and unique optical and electronic 
properties are some of the distinguishing features of TiO2 that make it a promising substrate in 
protein-based assays.13, 15, 21 Most recently, an optical interferometric biosensor based on TiO2 
nanotube arrays demonstrated the sensing of rabbit immunoglubin. 
The synthesis of TiO2 nanostructures is achievable using various top-down and bottom-up 
strategies, including sol-gel methods,2, 13 template-assisted methods,22 hydrothermal 
approaches,23-24 ultrasound irradiation25 and electrochemical means.26 In addition, the 
composition, structure, and dimension of TiO2 can be further tuned to optimize the performance 
of the TiO2-based biosensors. Although TiO2 has been explored in optical and electrochemical 
biosensing,15, 27 to the best of our knowledge, there is no report to date that explicitly examines 
the effects of the dimensions and geometries of nanostructured TiO2 on the performance of direct 
electron transfer with biomolecules. As a semiconductor, TiO2 itself has low conductivity. Our 
recent study has shown that carbon nanomaterials possess high conductivity and that carbon 
based biosensors exhibit considerable longevity.28 In this study, we hypothesized that the large 
surface area and biocompatibility of TiO2 nanowires in conjunction with the high conductivity 
and easy functionalization of a carbon thin layer might allow for the effective immobilization of 
proteins such as enzymes to develop high-performance biosensors. These hybrid TiO2 nanowires 
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may represent an efficient approach for „plugging‟ an electrode into an enzyme. Thus, the 
objective of this study is to explore whether it might be possible to facilitate the direct 
electrochemical detection of glucose using carbonized titanium oxide nanowires with a specific 
dimension. 
7.2. Experimental 
7.2.1. Materials  
The buckypaper used in this study was produced by the High-Performance Materials 
Institute of Florida State University with a thickness of 0.035 mm. Glucose oxidase (EC 1.1.3.4, 
Type VII from Aspergillus niger) and β-D-glucose were purchased from Sigma and were used as 
received. Chitosan was purchased from Aldrich and titanium foils (99.2%) from Alfa Aesar. 
Horseradish peroxidase (HRP), potassium ferricyanide (K3Fe(CN)6), ascorbic acid, uric acid, 3-
acetamidophenol were purchased from Sigma–Aldrich. All other reagents were of analytical 
grade. Water was puriﬁed with the Nanopure® water system (18 MΩ.cm) and was used in the 
preparation of all solutions. Various stock concentrations of β-D-glucose were prepared in 0.1M 
phosphate buffer, pH 7.4 and stored at 4 ºC. Glucose stock solutions were allowed to mutarotate 
overnight prior to use. 
7.2.2. Synthesis and modification of TiO2 nanowires 
TiO2 nanowires were prepared using a H2O vapor assisted thermal oxidation process in the 
presence of potassium fluoride (KF). The procedure is described briefly below. Titanium plates 
(1.25 cm × 0.8 cm × 0.5 mm) (99.2%, Alfa Aesar), were ultrasonically cleaned in acetone, 
ethanol and water. Initially, a predetermined volume of KF solution was applied to the surfaces 
of pre-treated Ti plates (etched in 18% HCl at 85 oC for 15 min), after which the Ti plates were 
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transferred to a ceramic boat. The ceramic boat was next inserted into a quartz tube. After being 
purged with Argon for 1 h, the gas flow was switched to H2O vapor. Subsequently, the quartz 
tube was heated to different temperatures (600 and 650 oC), which were maintained for 3 h. After 
thermal treatment, the input gas was switched back to a pure Argon flow until the furnace cooled 
to room temperature. Finally, the as-synthesized samples were rinsed several times using 
distilled water to remove any residual salts from the surfaces of the samples.  
In order to fabricate the carbon coated TiO2 nanowires, the as-synthesized TiO2 nanowire 
samples were inserted into a quartz tube.  After being purged with Argon for 1 h, the gas was 
switched to ethanol vapor. The quartz tube was then heated to 600 oC for 3 h. Following thermal 
treatment, the input gas was switched back to pure Argon until the furnace cooled to room 
temperature. The electrodes used in this work were carbonized under identical optimized 
conditions. 
7.2.3. Structure characterization 
The as-synthesized TiO2 nanowires and carbon coated TiO2 nanowires were characterized 
using scanning electron microscopy (JEOL JSM 5900LV) equipped with an energy dispersive X-
ray spectrometer (Oxford Links ISIS operated at 20 kV) and transmission electron microscopy 
(JEOL 2010 microscope). 
7.2.4. Biosensor preparation 
In order to engender TiO2 nanowires with the utility as a glucose biosensor, the electrodes 
were electrochemically activated.  To activate the carbon-modified TiO2 nanowire surface, cyclic 
voltammetry was performed in the range of -0.8 to 0.6 V at a scan rate of 10 mV.s-1 in 0.1 M 
phosphate buffer solution (pH 7.4) until steady-state current-voltage was obtained, after which a 
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potential of 1.5 V was applied to the electrode for 90 s. The activated surface was then ready for 
the immobilization of glucose oxidase. To immobilize the enzyme, the electrodes were dipped 
into a solution of 5 mg.mL-1 GOx (EC 1.1.3.4, Type VII from Aspergillus niger) containing 
0.01% Nafion. The adsorption of GOx on the nanowires was confirmed by monitoring the 
attenuation of the electrochemical signal obtained in 0.1 M phosphate buffer solution (pH 7.4). 
All prepared biosensors were stored at 4 ˚C in 0.1 M phosphate buffer solution at pH 7.4 when 
not in use. All reagents were of analytical grade. Water was puriﬁed with the Nanopure® water 
system (18 MΩ.cm) and was used in the preparation of all solutions. Stock solutions of β-D-
glucose were prepared in 0.1 M phosphate buffer at pH 7.4 and stored at 4 ˚C. Glucose stock 
solutions were allowed to mutarotate overnight prior to use. 
7.2.5. Electrochemical measurement 
Cyclic voltammetry and amperometric measurements were performed using an 
electrochemical workstation (CHI660, CH Instrument Inc., USA) connected with an in-house-
built, three-electrode glass cell (30 mL). A platinum coil was used as the counter electrode and 
was flame-annealed prior to each experiment. Ag/AgCl (3 M KCl) was used as the reference 
electrode. The constructed biosensors were employed as the working electrodes. Cyclic 
voltammetry was conducted before and after carbonization in a solution of 20 mM K3Fe(CN)6 + 
0.1 M KCl in 0.1 M phosphate buffer (pH 7.4) at a scan rate of 20 mV.s-1. All measurements 
were conducted at room temperature (22 ± 2 °C). 
7.2.6. TiO2 nanowire based biosensing experiment 
Electrochemical signals were measured through cyclic voltammetry prior to and following 
GOx immobilization, as well as upon injection of glucose in a 0.1 M phosphate buffer (pH 7.4) at 
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a scan rate 20 mV.s-1. The detection limit was calculated through S/N=3. At least five 
independent trials were used to generate each data set described in the above article. In order to 
evaluate the electron rate coefficient and constant, CVs were conducted at a scan rate range of 5 
to 500 mV.s-1 in the buffer solution (pH 7.4). To investigate the selectivity of the biosensor, we 
tested its response to common interfering species including ascorbic acid (AA), uric acid (UA) 
and acetamidophenol (AP) at their physiological concentration levels.  
7.2.7. Human serum glucose measurement 
These measurements were performed by chronoampermetry at the potential of 0.35 V for 
100 s in a diluted and undiluted human serum sample. The human serum was derived from male 
AB plasma (from Sigma). Comparison tests were performed with a commercially available 
Blood Glucose Monitoring System with the brand name of Ultra2®. The data were collected 
from five samples for each concentration.  
7.3. Results and discussion 
Scheme 7.1 illustrates the procedure proposed in this study for the fabrication of the TiO2 
nanowire based biosensor. A facile thermal oxidation (TO) method was developed for the direct 
growth of TiO2 nanowires with different dimensions on Ti substrates (Scheme 7.1a & b). 
Subsequently, a thin layer of carbon was deposited on the surfaces of the TiO2 nanowires using 
chemical vapour deposition (Scheme 7.1c). Finally, glucose oxidase was immobilized onto the 
carbonized TiO2 nanowires activated using facile electrochemical method (Scheme 7.1d).  
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7.3.1. Surface morphological studies 
To study the size effect, we explored whether a thermal oxidation method might be 
employed in the creation of TiO2 nanowires with different dimensions, as it has been used 
previously in the synthesis of one-dimensional silica and ZnO nanostructures.29-31 We 
successfully developed and modified the TO technique to directly grow TiO2 nanowires with 
controllable dimensions. Figure 7.1  and 7.2 show typical SEM images of the TiO2 nanowires 
having a length of ~ 1 µm (Figure 7.1) and ~ 2 µm (Figure 7.2), grown at 600 and 650˚C, 
respectively, for 3 h on titanium plates.  
 
 
Scheme 7.1. Diagram for the preparation of the TiO2 nanowire based biosensor. (a) a bare 
titanium plate; (b) TiO2 nanowires grown on titanium plate by H2O assisted thermal oxidation 
method; (c) deposition of a thin layer of carbon on TiO2 nanowires by CVD ; (d) immobilization 
of enzyme. 
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The electron diffraction pattern in Figure 7.3A facilitated the identification of the crystal 
structure of the TiO2 nanowires as being in the tetrahedral rutile phase.  
 
 
 
 
 
 
 
Figure 7.1. SEM images of carbon-modified TiO2 nanowires with dimensions of 50 nm × 1 µm. 
 
 
 
 
 
 
 
Figure 7.2. SEM images of carbon-modified TiO2 nanowires with dimensions of 80 nm × 2 µm. 
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Figure 7.3. SAED pattern of nanowires (A), and the corresponding EDS spectrum (B). 
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EDS shows a very strong peak for carbon that was deposited on the surfaces of TiO2 
nanowires using CVD (Figure 7.3B). Two additional peaks are related to titanium and oxygen. 
The small peak associated with potassium emerges from the remnants of the precursors. The 
TEM images of an individual TiO2 nanowire are shown in Figures 7.4 and 7.5. Hemicylindrical-
shaped TiO2 nanowires with dimensions of ca. 50 nm × 1 µm (Figure 7.4) and 80 nm × 2 µm 
(Figure 7.5) were observable. From the cross-sectioned SEM images and the TEM images, it was 
estimated that the number of the formed nanowires could be up to 3.1 × 1010 and 1.6 × 1010 per 
cm2 with the length of 1 and 2 µm, respectively. 
 
 
 
 
 
 
 
 
 
Figure 7.4. TEM images of an individual TiO2 nanowire with dimensions of 50 nm × 1 µm 
200 nm 
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Figure 7.5. TEM images of an individual TiO2 nanowire with dimensions of 80 nm × 2 µm. 
 
7.3.2. Electrochemical characterization  
Figure 7.6A presents the cyclic voltammograms (CVs) of the TiO2 electrode with nanowire 
dimensions of ~50 nm × 1 µm (denoted as Electrode1) prior to and following carbonization 
recorded in a K3Fe(CN)6 solution. A pair of well-defined redox peaks appeared at 0.323 and 
0.182 V before carbonization and at 0.312 and 0.186 V after carbonization. Obviously, 
carbonization improved the electron transfer rate as the peak-to-peak separation decreased ~15 
mV. In addition, with carbonized TiO2 nanowires a huge increase of the peak current from 99.04 
to 4305 µA was observed. Under the same conditions, the CVs of the TiO2 electrode with  
500 nm 
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Figure 7.6. Cyclic voltammograms of the TiO2 electrodes with nanowire dimensions of 50 nm × 
1 µm (Electrode1) (A) and 80 nm × 2 µm (Electrode2) (B) before (a) and after (b) carbonization 
at the scan rate of 20 mV.s-1 in K3Fe(CN)6 + 0.1 M KCl + PBS solution at pH 7.4. 
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nanowire dimensions of ~80 nm × 2 µm (denoted as Electrode2) exhibited current response 
peaks of 56.80 and 2063 µA at 0.333 and 0.151 V before and after the carbonization, 
respectively (Figure 7.6B). This indicates that a much higher surface area and conductivity were 
achieved with Electrode1 configuration, in contrast to that of Electrode2. The aggregated 
structure of Electrode2 results in a diminished active surface area, which imposes physical limits 
on electron transfer. The above results indicate that by decreasing the dimensions of the TiO2 
nanowires 80 nm × 2 µm to 50 nm × 1 µm, the electron transfer efficiency improves 
significantly. 
Electron transfer between the active site of glucose oxide (GOx) and the electrode surface 
is the limiting factor in the operation of electrochemical glucose biosensors. To investigate 
whether the fabricated TiO2 nanowires are capable of communicating with the active sites of 
proteins, we immobilized GOx as a probe. To assess the ideal nanowire dimensions that will 
enable the establishment and tailoring of the electrical contact between the redox center of GOx 
and the electrode surface, we tested four different electrodes. The first two electrodes were 
designated Electrode1 and Electrode2. Additional two electrodes were comprised of a TiO2 film 
and a bare titanium plate, which was devoid of nanostructuring. The latter two electrodes were 
utilized as controls. Using the equations described by Sheesan and Whitman, we subsequently 
calculated the time required for the monolayer of GOx to be adsorbed onto the nanosensors.
32-33 
For the control electrodes, GOx was immobilized over a range of time intervals in order to obtain 
optimum results. 
To assess electrode coverage and immobilization efficiency, cyclic voltammetry was 
conducted with the electrodes before and after the immobilization of GOx in a buffer solution at 
pH 7.4. As expected, the CV of the carbonized Electrode1 is featureless in the potential range of 
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-0.2 to 0.5 V in a phosphate buffer solution (Curve a of Figure 7.7A), while subsequent to the 
immobilization of GOx, the electrode generates a pair of well-defined redox peaks at 0.203 and 
0.154 V with an oxidation current peak of 7.64 µA (Curve b of Figure 7.7A). These redox peaks 
are attributed to the active sites of GOx, identified as flavin adenine dinucleotide (FAD).  
Accordingly, the formal potential of GOx on the TiO2 nanowires is 0.178 V, which is more 
positive than the redox potential of the FAD/FADH2 couple, -0.15 V (vs. Ag/AgCl).
34-35 It is 
surmised that this overpotential might originate from a barrier introduced by the TiO2 nanowires, 
which bridges the enzyme to the bulk electrode. In contrast, the CV of Electrode1 prior to 
carbonization shows no redox peaks upon the immobilization of GOx since the conductivity of 
the uncarbonized TiO2 nanowires is not sufficient for the electron transfer process (Figure 7.7B).  
Under the same conditions, the CVs of Electrode2 were devoid of any defined redox peaks 
(Figures 7.8A and 7.8B). However, following GOx immobilization, the redox peaks attributed to 
the carbon-oxygen functionalities28 is broadened, which indicates the blockage of some active 
parts of Electrode2 by the enzyme (Figure 7.8A).  
The amount of the electroactive GOx immobilized on Electrode1, Γ = Q/nFA, (where Q is the 
charge, n is the electron transfer number, F is the faraday constant, and A is the geometric 
surface area of the working electrode), was calculated to be 7.11 × 10-11 mol.cm-2. Thus, the 
number of active GOx molecules on the electrode surface is 4.28 × 10
13 per cm2, which 
corresponds to 86% coverage with a random, densely packed GOx monolayer. This value is ~ 50 
fold larger than the number of GOx immobilized on a smooth surface, since each molecule of 
GOx occupies an area of ~100 nm
2.36-37 The Γ calculation for Electrode2 was somewhat dubious 
since the redox peaks of GOx were not salient enough. 
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Figure 7.7. Cyclic voltammograms of carbon-modified Electrode1 (A), and un-carbonized 
Electrode1 (B), before (a) and after (b) immobilization of GOx recorded at the scan rate of 20 
mV.s-1 in PBS pH 7.4. 
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Figure 7.8. Cyclic voltammograms of carbon-modified Electrode2 (A), and un-carbonized 
Electrode2 (B), before (a) and after (b) immobilization of GOx recorded at the scan rate of 20 
mV.s-1 in PBS pH 7.4. 
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In order to evaluate the impact of nanostructuring on the efficiency of GOx immobilization, 
the CVs of the Electrode1 were obtained at different scan rates (Figure 7.9A). The plot of ΔEp vs. 
log ν is displayed in Figure 7.9B, where ΔEp is the potential separation of the anodic and 
cathodic peak, and ν is the scan rates. The peak-to-peak separation is linearly dependent on the 
logarithm of the scan rates when ΔEp > 200/n, where n is the number of electrons involved in the 
reaction. This is in good agreement with Laviron theory.38 
The experimental electron transfer coefficient α was thus calculated to be 0.43. This 
confirms our hypothesis that the carbonized TiO2 nanowires may plug into the reaction center of 
GOx. From this plot, we further estimated the interfacial electron transfer rate constants (ks) to be 
1.27 s-1. This ks value is quite similar to the ones reported in the literature for direct electron 
transfer of GOx on carbon nanotubes,
39-40 indicating that the carbonized TiO2 nanowire behaves 
individually and that the faradaic current increases significantly due to the large active area.  
There is a great interest in developing mediator-free electrochemical biosensor for glucose 
monitoring in diabetes management.  Since the direct electron transfer of GOx immobilized on 
the carbonized TiO2 nanowires was observed, we further explored whether the immobilized GOx 
could be effective to detect glucose in the absence of a mediator. Figure 7.10 presents the CVs of 
Electrode1 recorded in a phosphate buffer solution in the absence (Curve a) and in the presence 
of glucose (Curve b).   
As shown in Figure 7.10, after the injection of glucose, an oxidation current appeared at 
~0.1 V and increased with the increase of the electrode potential up to 0.20 V; it retained the 
maximum value in the potential range from 0.2 to 0.4 V. 
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Figure 7.9. (A) Cyclic voltammograms of Electrode1 after GOx immobilization at different scan 
rates (20, 50, 100, 200, 300, 400, 500 mV.s-1), and (B) Laviron plots corresponding to the 
separation between redox peaks of the CVs as a function of scan rates.  
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In the presence of oxygen, the cyclic voltammogram of Electrode1 showed greatly increased 
reduction peak current (curve a, Figure 7.10), while the oxidation peak current decreased, 
showing an obvious electrocatalytic process toward the reduction of dissolved oxygen according 
to the following equations: 
GOx (FAD) + 2e
- +2H+ →  GOx (FADH2)    (1) 
GOx (FADH2) + O2  →  GOx (FAD) + H2O2    (2) 
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Figure 7.10. Cyclic voltammograms of Electrode1 after GOx immobilization in O2 saturated 
PBS at pH 7.4 (a) and upon addition of 2 mM glucose (b). 
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Figure 7.11. (A) Chronoamperometric response of Electrode1 after GOx immobilization in O2 
saturated PBS at pH 7.4 upon injection of different concentrations of glucose, and (B) the 
corresponding calibration curve.  
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This was a typical EC catalytic process, in which oxygen regenerated GOx (FAD) and enhanced 
the reduction peak current of FAD. When glucose was added into this system, the reduction peak 
current decreased (curve b, Figure 7.10). Thus the glucose restrained the electrocatalytic reaction 
due to the enzyme-catalyzed reaction between the oxidized form of GOx, GOx (FAD), and 
glucose, Equation (3): 
Glucose + GOx (FAD) → Gluconolactone+GOx (FADH2)    (3) 
With increasing glucose concentration, the peak current for the electrocatalytic reduction 
decreased, while the oxidation peak current increased, producing a glucose biosensor. To 
determine the linear dynamic range of the carbonized TiO2 nanowire based biosensor, Electrode1 
was tested when exposed to different concentrations of glucose at E = 0.35 V (Figure 7.11A and 
B). The linear current response range was wide, up to ~18 mM, which is well beyond the normal 
physiological glucose level (3 - 8 mM). The sensitivity and detection limit of biosensor were 
calculated to be 15.0 µA.mM-1.cm-2 (RSD = 3%, N = 5) and 0.4 mM (S/N = 3), respectively. For 
comparison, Electrode2 was also tested under the same conditions; a narrow linear range (1- 6 
mM) and a low sensitivity, 4.2 µA.mM-1.cm-2 (RSD = 5%, N = 5), were obtained for its response 
to glucose. In contrast, the GOx immobilized on the TiO2 thin film and the titanium plate without 
nanostructuring could not generate a detectable response.   
7.3.2. Selectivity of the TiO2 Nanowire based biosensor 
We further studied the selectivity of the carbonized TiO2 nanowire based biosensor.  
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Figure 7.12. Chronoamperometic response of Electrode1 after GOx immobilization to 
interference species (0.1 mM uric acid (UA),0.1 mM 3- acetamidophenol (AP), and 0.1 mM 
ascorbic acid (AA)) (a) and in the presence of 2 mM (b) and 4 mM (c) glucose in PBS at pH 7.4. 
As seen in Figure 7.12, the four i – t curves of Electrode1 recorded in 0.1M PBS and upon 
subsequent injection of ascorbic acid, uric acid and acetamidophenol were overlapped (Curve a), 
showing that the fabricated biosensor is insensitive to the common interfering species. In 
contrast, the salient response to glucose was observed upon the further injections of 2 mM 
glucose (Curve b and c of Figure 7.12) with the same high sensitivity measured in the absence of 
the interfering species shown in Figure 7.11A. 
7.3.3. Real sample analysis 
The carbonized TiO2 nanowire based biosensor was further tested using a real sample, human  
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Figure 7.13. Chronoamperometic response of Electrode1 after GOx immobilization to diluted (a) 
and undiluted (b) human serum samples. 
 
serum with a normal glucose level. Figure 7.13 presents the chronoamperograms of a diluted 
serum sample (in a 0.1 M phosphate buffer solution, pH 7.4) (Curve a) and an original undiluted 
serum sample (Curve b). Their corresponding glucose concentration were calculated to be 4 ± 
0.01 mM (N = 5) and 5.1 ± 0.01 mM (N = 5), respectively. Those values were in excellent 
agreement with the data obtained by a commercial blood glucose monitoring assay, showing that 
the carbonized TiO2 nanowire based biosensor is amenable in medical diagnostics. 
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7.4. Conclusion 
In summary, the results described herein represent an important advance in understanding 
the size effect of nanomaterials on electron transfer of immobilized biological species and 
provide insights in the development of high-performance biosensing systems. We have 
developed a facile approach for the synthesis of TiO2 nanowires with controllable dimensions. 
As demonstrated here, the carbonized TiO2 nanostructures with different dimensions interact 
dissimilarly with GOx. We discovered that GOx requires a TiO2 nanowire sensing entity that is 
smaller than 80 nm × 2 µm in order to sufficiently promote the direct electron transfer 
throughout the nanosensor and to react with glucose. Our study has revealed that the carbonized 
TiO2 nanowires with a diameter of ~50 nm and a length of ~1µm are capable of communicating 
with the prosthetic group of enzymes with a relatively high interfacial electron transfer rate in the 
absence of a mediator. The developed carbonized TiO2 nanowire based glucose biosensor 
exhibits a wide linear range up to 18 mM, high sensitivity and selectivity. In addition, as 
previous studies have shown, TiO2 is inherently biocompatible,
41  its stability can be further 
enhanced upon protein adsorption, and its protein-conjugated implants do not release particulates 
into surrounding tissues.42 Thus, we believe that the carbonized TiO2 nanowire based biosensors 
warrant further study for in vivo analysis, with the aim of developing implanted biosensing 
devices. 
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Chapter 8 
Synthesis and Electrochemical Study of Nanoporous Palladium-
Cadmium for Non-Enzymatic Glucose Detection 
8.1. Introduction 
Over the past few decades strategies for the design of glucose sensing systems have been 
focused on development of suitable techniques that enable high sensitivity and selectivity at low 
cost. The importance of glucose monitoring originates from its applications in the food industry, 
blood diagnostics and fuel cells. Since glucose oxidase is selective to glucose and shows fairly 
stable activity in a pH range of 2 to 8,1-2 it has been widely used to construct various 
amperometric biosensors for glucose detection. Efforts to develop and improve glucose sensors, 
particularly based on amperometry, have proceeded over five decades since Clark and Lyons 
first reported the development of an enzyme-based electrode in 1962.3 Subsequently, in 1967, 
Updike and Hicks incorporated glucose oxidase (GOx) within a gel on an oxygen electrode and 
detected glucose concentrations in a biological fluid.4 As the reaction centers of enzymes are 
isolated, the transfer of electrons between glucose oxidase and the electrode surface may be 
enhanced by the integration of a variety of synthetic mediators into the structures of enzymatic 
glucose sensors.2, 5 However, mediators have the tendency of leaching into the test solution and 
hence, create an unstable/unreliable response. To diminish the necessity of utilizing synthetic 
mediators, glucose sensors were investigated for transferring electrons directly from the enzyme 
to the electrode by electrically wiring its active redox site to the electrode surface. Thus, 
regardless of the concentration of co-substrates such as oxygen or redox mediators, direct 
157 
 
electron transfer could transform the enzymatic oxidation process of glucose into an 
amperometric signal. The most important advantage of this design is the selective response of the 
electrode to glucose in the presence of additional electroactive interfering species. However, GOx 
quickly loses its activity at pH levels of below 2 and above 8, as well as in solutions that contain 
ionic detergents.6 Furthermore, the thermal and chemical instability of GOx limits enzymatic 
glucose sensors from being amenable for the continuous monitoring of fermentation processes or 
within the human body where sterilization is required. Aside from temperature, pH, and toxic 
chemicals, the responses of enzymatic glucose sensors may be influenced by humidity. 
Fluctuations in humidity may be significantly harmful to the activity of electrodes when they are 
in use as well as during storage,7-8 with the result of providing unreliable data. To overcome 
these drawbacks, the electrocatalytic oxidation of glucose without the use of enzymes has been 
increasingly investigated.9-29 Continued efforts toward the development of this idea have 
culminated in the realization of the electrocatalytic oxidation of glucose and its mechanism on 
bare metal surfaces. Early mechanistic studies revealed that glucose oxidation on metal surfaces 
suffers from very slow kinetics, which is unable to generate significant faradaic current. Most 
pure metals, including platinum, exhibit an unsatisfactory sensitivity to glucose. For example, the 
sensitivity of flat platinum with a roughness factor of 2.6 in a phosphate buffer barely exceeds 
0.14 µAcm−2 for 6 mM glucose. Besides low sensitivity, platinum electrodes are subject to 
poisoning via the adsorption of intermediates that arise from glucose oxidation,21 which results in 
poor selectivity. This phenomenon further reduces the activity of platinum-based glucose 
sensors. In addition, the absence of enzymes leads to non-specific electrode responses to other 
electroactive species such as ascorbic acid.   
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Regarding its mechanism of operation, the electrochemical oxidation of glucose molecules 
involves the complex processes of adsorption, electron transfer, and subsequent chemical 
rearrangement, which are combined with the reactions on the surfaces of the electrocatalysts.2 
On the other hand, amperometric studies of glucose oxidation using conventional electrodes 
showed that the electrochemical performance of enzyme-free electrodes is heavily influenced by 
the pH of the test solution, and that their maximum response current can be achieved when the 
evaluation is performed under high pH conditions (0.1 M NaOH solution).10-11, 13-16 In contrast, 
exposing electrodes to a highly basic medium inevitably causes surface degradation and imposes 
limits on the longevity of the electrocatalysts.30 To overcome the aforementioned drawbacks 
toward the design of a high performance glucose oxidation system, the electrocatalytic activity of 
enzyme-free electrodes are of great interest insofar as investigations into cathodic operation 
potentials (to minimize the interfering effects of electroactive species), and neutral pH conditions 
(to avoid electrocatalyst surface damage).  
In recent years, three dimensional nanomaterials have been investigated for their 
electroanalytical performance in a broad range of applications, from batteries to sensors. For 
example, precious metal nanoparticles15, 24, 31 have exhibited efficient electrocatalytic activity in 
response to glucose oxidation. These results illustrated that the faradic current responses of 
nanomaterial-based electrodes are influenced by both the structure and resident active sites of 
nanomaterials. However, further broad-based applications are somewhat limited as these 
materials are costly, and they suffer from surface poisoning. Alternately, transition metals and 
their alloys have been extensively explored.12, 14, 16, 25-27, 30 Among the transition metals, Pd-based 
alloys offer a class of practical materials for gas sensing32 and other catalytic applications.33-34 
The application of these materials would be expanded by their compatible combination with an 
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appropriate electroactive transition metal such as cadmium to develop binary nanostructured 
building blocks. The dimensions, geometries, and composition of these nanomaterials may be 
manipulated to further improve the performance of glucose electrooxidation. 
In this work, for the first time, we report on the fabrication and characterization of a non-
enzymatic electrode for the direct oxidation of glucose in a mediator-free based upon palladium-
cadmium (PdCd) nanostructured materials. The Pd-Cd binary nanostructure was synthesized via 
a labile, convenient, template-free, single-step hydrothermal method.  The surface morphology, 
composition and crystal structure of the resultant nanoparticles were investigated in detail. The 
fabricated glucose sensor was configured to measure glucose with high sensitivity and selectivity 
under a wide range of potentials and pH.  
8.2. Experimental 
8.2.1. Materials 
PdCl2 (Alfa Aesar, 99.9%), Cd(NO3)2 (Alfa Aesar, 99.9%), ammonium formate (Aldrich, 
99.995%), d-glucose (Sigma), ascorbic acid (AA) (Sigma-Aldrich), uric acid (UA) (Sigma), and 
3-acetamidophenol (AP) (Aldrich) were used as received. All chemicals were of analytical grade. 
The phosphate buffer solution (PBS, 0.1 M, pH 7.4) was comprised of Na2HPO4 and NaH2PO4. 
Solutions of glucose, AA, UA and AP were prepared using PBS immediately before each 
experiment. Glucose stock solutions were allowed to mutarotate overnight prior to use. Nanopure 
water (18.2 MΩ cm) was utilized in the preparation of all solutions. 
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8.2.2. Fabrication of PdCd/GC Electrode 
A hydrothermal method was employed in the synthesis of variably composed nanoporous 
PdCd. Briefly, a solution of PdCl2 0.05 M and Cd(NO3)2 0.05 M precursors with stoichiometric 
ratios, and 1 ml ammonium formate (10 M) serving as the reducing agent was diluted to 10 ml 
with water and transferred to a Teflon-lined autoclave. The autoclave was subsequently sealed, 
and heated at 180oC for 2 h. After cooling to room temperature, the PdCd nanomaterials were 
rinsed, ultrasonicated and centrifuged three times. Glassy carbon electrodes (GC, 3 mm in 
diameter, CH Instruments) were polished with alumina powder prior to each experiment, rinsed 
thoroughly with doubly distilled water, and ultrasonicated in 1:1 HNO3, ethanol and water for 15 
min, after which they were allowed to dry at room temperature. A solution consisting of 3 µl of 6 
mg/ml PdCd nanomaterials in Nafion® (0.5% in methanol) was then added to the GC electrodes. 
The electrodes were allowed to dry at room temperature. 
8.2.3. Instruments and Electrochemical Experiments 
All electrochemical experiments were performed using an electrochemical workstation 
(CHI660B, CH instrument Inc.), interfaced with an in-house-built, three-electrode glass cell (50 
mL). A platinum coil was used as the counter-electrode and was flame-annealed before each 
experiment. Ag/AgCl (saturated KCl) was used as the reference electrode. GC electrodes coated 
with Pd-Cd nanoparticles was employed as the working electrodes. Amperometric measurements 
of glucose were carried out in a 0.1 M phosphate buffer solution (pH 7.4) at selected potentials. 
Currents at each glucose concentration were recorded subsequent to the onset of transient steady 
states, which were attained under the constant stirring of the solution. All solutions were de-
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aerated with ultrapure argon (99.999%) prior to measurements, and argon was passed above the 
solution during the experiments. All measurements were conducted at room temperature.  
8.3. Results and discussion 
8.3.1. Morphological characterization of nanoporous PdCd  
Figures 8.1 and 8.2A present a typical SEM image and EDS spectrum of the nanoporous 
PdCd, respectively which were synthesized by a hydrothermal method. The SEM image reveals 
that the three-dimensional random porous structures, with diameters of tens to hundreds of 
nanometers, were formed by the close proximity of the PdCd nanoparticles, with a size range of 
from 50–500 nm. Solitary Pd and Cd peaks appear in the EDS spectrum, and no discernible 
carbon or oxygen signals are seen in this spectrum. This verified that the synthesized nanoporous 
PdCd was free of organic surface-resident impurities. 
 
 
 
 
 
 
 
Figure 8.1. Typical SEM image of the nanoporous PdCd.  
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Figure 8.2. (A) the EDS spectrum and  (B) XRD patterns of the prepared nanoporous PdCd film.  
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The crystalline nature of the Pd nanomaterials in nanoporous PdCd was confirmed by XRD 
studies, as shown in Figure 8.2B.  The pattern of the PdCd nanostructures depicts all of the major 
peaks of palladium at 39.33(111), 45.71(200), 66.97(220) and 80.65(311) which are shifted 
slightly to smaller 2θ values, rather than pure palladium, 42.02 (111), 46.56 (200), 68.04 (220), 
and 82.05°(311).  This is indicative of increased d-spacing and a dilation of the lattice constant, 
due to the incorporation of the Cd atoms into the Pd fcc lattice.34 The XRD pattern of Pd 
nanomaterials is in good agreement with that of the reference pattern for the fcc (face centered-
cubic) palladium (JCPDS 46-1043). No hexagonal Cd peaks appear, indicating that alloyed Pd-
Cd intermetallic nanostructures were formed.  
8.3.2. Evaluation of the electrochemical performance of the PdCd/GC electrode 
To assess whether the percentage of cadmium has an impact on the electrochemical 
behaviour of the electrodes, cyclic voltammetry was conducted for the electrodes containing 
nanoporous PdCd with the ratio of (Pd:Cd) 100:0, 90:10, 80:20, 70:30 in a phosphate buffer 
solution (0.1 M, pH 7) at the scan rate of 50 mV.s-1 and at the potential range of -1000 to 400 
mV . As shown in Figure 8.3, by increasing the percentage of cadmium up to 20%, both the 
oxidation and reduction peak currents increase. Conversely, a current decrease is indicated when 
30% cadmium was introduced into the nanoporous structure, signifying that cadmium lowers the 
activity of the fabricated binary nanostructure when the ratio of PdCd exceeds 80:20. We further 
studied the electrocatalytic response of the electrodes in the presence of 1 mM glucose in the 
PBS buffer solution (0.1 M, pH 7).  
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Figure 8.3. Cyclic voltammograms of Pd-Cd/GC electrodes with (a) 0%, (b) 10% (c) 20% (d) 
and 30% loadings of Cd, in PBS (0.1M, pH 7) at a scan rate of 50 mV.s-1.  
Figure 8.4 presents the CVs of the glassy carbon electrode containing Pd:Cd 80:20, prior to, and 
following the addition of 1 mM glucose. In the absence of glucose, the voltammogram of the 
electrode shows the characteristic features of palladium-cadmium, including the hydrogen 
adsorption/desorption waves at a negative potential region (-1000 to -400 V); a flat double layer 
region at intermediate potential (-400 to -150 V); and the cadmium oxide and palladium oxide 
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Figure 8.4. Cyclic voltammograms of the Pd-Cd/GC electrode in PBS (0.1M, pH 7.4) in the 
absence (solid line) and presence (dashed line) of 1 mM glucose at a scan rate of 50 mV.s-1 in 
PBS solution (pH 7). 
formation region at the positive potentials (0 to 400 V). Cathodic peaks at ca. -300 and -600 V 
corresponding to the reduction of palladium oxide and cadmium oxide are observed in the 
negative potential scan.35 Upon the addition of glucose (1 mM), the voltammetric characteristics 
of the PdCd/GC electrode with 20% cadmium change drastically and show a very complicated 
electrochemical behavior. However, the CVs of the other three electrodes containing 0, 10 and 
30% cadmium did not show any salient response to glucose.  Therefore, the PdCd20% electrode 
was selected for further evaluation. As shown in Figure 8.4, the GC electrode containing 
PdCd20% shows a strong current response towards the electro-oxidation of glucose and its 
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intermediates at a variety of potentials.  At low potential, the first peak emerges at -500 mV and 
broadens with increasing glucose concentrations, which might be attributed to the electrosorption 
of glucose; forming glucose intermediates such as enediols.  At potentials of above -450 mV the 
further oxidation of glucose and its intermediates may occur, forming products such as 
gluconolactone or gluconic acid.21   
8.3.3. Effect of potential and pH on the PdCd/GC electrode 
The electrocatalytic performance of nanomaterials may generally be evaluated by 
measuring current at fixed operating potentials in the presence of a specific analyte. Hence, for 
the electrochemical sensing of glucose, it is critical to define an optimum detection potential, at 
which a maximum current response for glucose oxidation is achievable. The electrooxidation of 
glucose on a PdCd20%/GC electrode was investigated at operating potential range of -600 to 400 
mV utilizing amperometry. Figure 8.5A illustrates the dependence of the glucose current 
response of the electrode on the operating potential. The current response in the presence of 3 
mM glucose decreased when the cathodic potential was lowered from -600 to -400 mV. 
However, we witnessed an improvement in the standard deviation of the electrode response at-
400 mV (RSD = 4.3%). By further decreasing the cathodic potential to -300 mV, the response 
current declined significantly. 
The change in current nearly diminished to the potential range of -200 to 200 mV. At 300 mV, a 
jump in the response current was observed while the standard deviation increased (RSD = 10%). 
Therefore, an operating potential of -400 mV was selected as an optimal value, since a large and 
reliable response of the electrode to glucose was obtained at this potential. 
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Figure 8.5. (A) Dependence of catalytic current of the Pd-Cd/GC electrode at different applied 
potentials measured in PBS (0.1M, pH 7) containing 3 mM glucose. (B) Effect of pH on the 
catalytic current of the Pd-Cd/GC electrode in PBS containing 3 mM glucose. 
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To study the effect of pH on the electrocatalytic activity of the electrode, amperometry was 
conducted in pH range of from 2 - 9 in the presence of 3 mM glucose. As shown in Figure 8.5B, 
the electrode response current increases in conjunction with elevated pH levels. However, the 
standard deviation for five different electrodes reached 12% at pH 9.0. In addition, unlike most 
other non-enzymatic sensors,10-11, 13-16 the present sensor system demonstrates remarkable 
performance without surface contamination at neutral pH (PBS buffer 0.1 M), which makes it an 
excellent candidate for practical applications. 
8.3.4. Amperometric performance of PdCd20%/GC electrode in the oxidation of glucose  
To study the performance of the electrode in the continuous monitoring of glucose, the 
electrochemical responses of the electrode were examined upon the injection of different 
concentrations of glucose. The response current was continuously recorded at -400 mV in a 
phosphate buffer solution (pH 7) while the solution was being constantly stirred. As is shown in 
Figure 8.6A, the current for the electrooxidation of glucose at the PdCd20%/GC electrode 
increases in step with increasing glucose concentrations up to 10 mM. The sensitivity calculated 
from the calibration curve (Figure 8.6B) is 146.21 µAmM−1cm−2 (y=10.33x+1.70, R = 0.9975) 
with a detection limit of 0.05 mM (S/N = 3). The high sensitivity of the fabricated sensor may be 
ascribed to the extensive surface area of nanoporous PdCd in conjunction with the high 
electrochemical activity of the binary nanostructured system, which can in turn guarantee the 
accessibility of glucose to the active surface domains of the electrode. Electrode-to-electrode 
reproducibility was examined and validated through the fabrication of five distinct electrodes, 
which were constructed under identical conditions and compositions. Accordingly, the relative 
standard deviation, following the evaluation of the five electrodes, was estimated to be 5%. 
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Figure 8.6. (A) Amperometric response to successive additions of 1mM glucose into PBS 
(0.1M, pH 7) at -0.4V; (B) and the corresponding calibration curve for the response of the Pd-
Cd/GC electrode. 
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In addition, the time required for the electrode to reach 95% of the steady-state current response 
to glucose was about 8 s (Figure 8.6A).  
 
Table 8.1 Comparison of different glucose sensors based on nanostructured materials. 
Electrode Sensitivity 
(µAmM−1cm−2) 
Linear dynamic 
range (mM) 
Operating 
potential (V) 
Pt-PbNA/Pt12 11.25 1-11 -0.20 
NPG29 41 0-15 0.2 
3DGF/ITO10 46.6 0.005- 10 -0.30 
AuNP15 160 1-8 0.25 
NiCFP16 420 2e-3 - 2.5 0.6 
Ni(OH)2 NP/FTO
36 446 0.01–0.75 0.4 
Pt/MCs28 8.52 0-7.5 0.1 
This work 146.21 0-10 -0.4 
Pt-PbNA: Pd-Pb nanowire array, 3DGF: three-dimensional inverse-opal gold film, ITO: Indium-
tin oxide; AuNP: Gold nanoparticles; NiCFP: Ni nanoparticle-loaded carbon nanofiber paste; 
Pt/MCs: Pt nanoparticles/mesoporous carbons; NPG: Nanoporous gold; Ni(OH)2 NP/FTO: 
Ni(OH)2 nanoparticle modified fluorine doped tin oxide. 
 
 
The sensor exhibited good stability and a negligible voltammetric current decrease was observed 
during continuous operation (RSD = 4.3%). To test the long-term stability of the electrode, it 
underwent testing for glucose monitoring once a week. The results revealed that the sensor 
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maintained nearly 90% of its initial current response to glucose after one month. Table 8.1 
compares the performance of the proposed sensor and other reported glucose sensors. 
8.3.5. Selectivity of glucose sensor in the presence of interferants 
To investigate the selectivity of the PdCd/GC electrode, we tested its response to the 
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Figure 8.7. Effect of interferants, 0.1 mM ascorbic acid (AA), 0.1 mM acetaminophen and 0.02 
mM uric acid (UA), on the response of the Pd-Cd/GC electrode in the presence of glucose in 
PBS solution (pH 7) at -0.4 V. 
 
common interferant species including 0.1 mM ascorbic acid (AA), 0.02 mM uric acid (UA) and 
0.1 mM acetamidophenol (AP). Figure 6 shows the amperometric response of the PdCd20%/GC 
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electrode to the interferants in the presence of 3 mM glucose. Clearly, there is no change in the 
current upon the addition of the interferants. Thus, the sensor allows for the highly selective 
quantiﬁcation of glucose at a negative potential and a neutral pH. 
8.4. Conclusions 
In summary, an enzyme-free glucose sensor was successfully fabricated, which was based 
on PdCd binary nanostructured system.  A hydrothermal method was used in the synthesis of 
nanoporous PdCd with variable compositions. The stable incorporation of PdCd nanostructures 
onto glassy carbon electrodes was facilitated by the use of Nafion®. The electrode exhibited a 
salient current response to electro-oxidation of glucose with high sensitivity and selectivity at an 
optimized potential. The resulting nanosensor is capable of sustainably detecting glucose via 
amperometry at the negative potential of -400 mV (Ag/AgCl), where interference from the 
oxidation of common interfering species such as AA, AP, and UA is effectively avoided. The 
electrode has a number of other desirable attributes including a low detection limit, short 
response time, satisfactory linear concentration range, excellent stability, and high 
reproducibility. In addition, the high sensitivity of the electrode to glucose at neutral pH (pH = 7) 
confirms its potential in multiple analytical applications. 
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Chapter 9 
Conclusion, Future Prospects and Challenges 
As the prevalence of diabetes is increasing worldwide and as curing of the two types of 
diabetes remains elusive, humanity is likely to further benefit from advances in monitoring of 
glycemia. In this regard, the enormous activity in the field of glucose biosensors is a reflection of 
the major clinical importance of the topic. Such huge demands for effective management of 
diabetes have made the disease a model in developing novel approaches for other types of 
biosensors for diagnosis of cholesterol, cancer, infections and other diseases.  
Electrochemical glucose monitoring has contributed massively to improving the lives of 
diabetic people. Accordingly, for nearly 50 years we have witnessed tremendous progress in the 
development of electrochemical glucose biosensors. Elegant research on new sensing concepts, 
coupled with numerous technological innovations, has thus opened the door to widespread 
applications of electrochemical glucose biosensors. Such devices account for nearly 85% of the 
world market of biosensors. Major fundamental and technological advances have been made for 
enhancing the capabilities and improving the reliability of glucose measuring devices. Such 
intensive activity has been attributed to the tremendous economic prospects and fascinating 
research opportunities associated with glucose monitoring. The success of glucose blood meters 
has stimulated considerable interest in in-vitro and in-vivo devices for monitoring other 
physiologically important compounds. Similarly, new materials (membranes, mediators, 
electrocatalysts, etc.) and concepts, developed originally for enhancing glucose biosensors, now 
benefit a wide range of sensing applications.  
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Even though progress in this field is rapid, the ultimate goal of achieving long-term, 
accurate and continuous glucose monitoring in patients has not yet been fulfilled, and there are 
still many challenges and obstacles related to the achievement of a highly stable and reliable 
continuous glycemic monitoring. Such monitoring of moment-to-moment changes in blood 
glucose concentrations is expected to lead to a substantial improvement in the management of 
diabetes. The motivation of providing such tight diabetes control thus remains the primary focus 
of many researchers. 
Nanoscale sensors have the potential to drastically improve continuous glucose monitoring 
capabilities and improve patient quality of life. Macrosensors can be compromised during 
implantation through the degradation of the sensor and fibrous capsule formation. Nanosensors 
might avoid these drawbacks, allowing more long-term monitoring and reaching the goal of a 
closed-loop artificial pancreas. Several questions remain about the ability for these approaches to 
impact clinical care, including biocompatibility and sensor lifetime.  
Therefore, the questions that need to be answered are: 
1. Can we design biosensors with biocompatible components? 
2. Can nanomaterials size and shape have an impact on the bio-recognition components in a 
biosensor?  
3. Can nanomaterials be designed to help improve sensor lifetime? 
4. Do nanomaterials improve current sensors at a level that offsets the increased cost of 
manufacture? 
5. Can nanoscale sensors minimize tissue encapsulation and protein fouling? 
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6. Can nanosensors be administered in locations to minimize glucose transport time lag? 
In the present dissertation, we devoted our full commitment and efforts to answer the first 
three questions. However, the last three questions need to be addressed through further research 
for patients to benefit from this technology. 
First, we demonstrated a novel glucose biosensor based on the highly efficient 
immobilization of GOx on a Prussian blue-modified nanoporous Au surface. The nanoporous Au 
was directly grown through a facile hydrothermal method and modified by electrodeposited 
Prussian blue (PB). Our study showed that owing to its large surface area and strong adsorption 
ability for enzyme binding, high chemical stability, low inherent toxicity and high conductivity 
the nanoporous Au substrate provides an excellent matrix for the immobilization of GOx. The 
small Km value of the biosensor indicates that the immobilized GOx possesses high enzymatic 
activity and that the fabricated biosensor exhibits a high affinity for glucose. Our electrochemical 
tests showed that the fabricated biosensor exhibits fast amperometric response, a low detection 
limit, extremely high sensitivity, good reproducibility and high selectivity for the detection of 
glucose.  
To adopt the excellent properties of nanoporous gold in a mediator-free biosensor, we 
modified its structure and fabricated a cholesterol biosensor by co-immobilizing enzymes 
(cholesterol oxidase, cholesterol esterase and horseradish peroxidise) on its surface. The 
immobilized cholesterol oxidase effectively catalyzes the oxidation of cholesterol while the 
cholesterol esterase catalyzes the hydrolysis of esterase-esterified cholesterol, thus allowing the 
determination of the total cholesterol. Meanwhile, the immobilized horseradish peroxidase 
(HRP) facilitates the detection of the H2O2 generated by the catalytic conversion of cholesterol to 
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cholest-4-en-3-one. The developed cholesterol biosensor showed high selectivity as tested 
toward common interfering species such as ascorbic acid, uric acid, lactic acid and glucose. A 
very low Michaelis-Menten constant indicates a very high activity of the immobilized enzymes. 
Under the physiological condition (pH 7.4), the designed biosensor exhibited reliable cyclic 
voltammetric responses, high sensitivity, and a wide linear range up to 300 mg.dl-1. The 
developed biosensor was also successfully used to measure the total cholesterol in real food 
samples. The high-performance along with the ease of fabrication and low costs makes the new 
biosensor promising for the detection of total cholesterol in both clinical diagnostics and the food 
industry. 
Furthermore, to improve the long-term stability of the biosensor we used buckypaper 
(aggregated carbon nanotubes) networks to design a mediator-free glucose biosensor based on 
the co-immobilization of GOx and HRP on the activated buckypaper. Direct electrochemistry of 
GOx on the buckypaper was observed. The glucose biosensor showed a high sensitivity, low 
detection limit, fairly wide linear dynamic range, over 80 days life-time for continuous 
monitoring of glucose. The selectivity response of the biosensor in the presence of common 
interferent species was studied under the physiological condition and the result showed that the 
biosensor is worth to be further tested in real sample analysis. These properties of the 
buckypaper-based biosensor, coupled with the biocompatibility of its components are important 
factors which could be attractive for real-time in vivo glucose monitoring and lead to a 
substantial improvement in the management of diabetes. The facile and robust buckypaper-based 
platform proposed in this study opens many opportunities for the development of high-
performance electrochemical biosensors for medical diagnostics and environmental monitoring. 
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According to our previous work carbon-based nanostructured biosensors exhibit 
considerable longevity. Thus, we developed a modified method to synthesize carbon-modified 
TiO2 nanowires with controllable size. As demonstrated in chapter 7, carbonized TiO2 
nanostructures, with different dimensions, interact differently with GOx. We discovered that GOx 
requires a TiO2 nanowire smaller than 80 nm × 2 µm in order to sufficiently promote electron 
transfer throughout the sensor and reaction with glucose in a continuous behavior. This confirms 
that the modified TiO2 nanowire is capable of communicating with the prosthetic group of 
enzyme.  The carbonized TiO2 nanowire based biosensor was further tested using a real sample, 
human serum with a normal glucose level. The values measured by the fabricated biosensor were 
in excellent agreement with the data obtained by a commercial blood glucose monitoring assay, 
showing that the carbonized TiO2 nanowire based biosensor is amenable in medical diagnostics. 
In addition, as previous studies showed TiO2 is inherently biocompatible and obtains more 
stability upon protein adsorption and its protein-conjugated implants do not release particles to 
the surrounding tissues. Therefore, we suggest that carbonized TiO2 nanoparticles can further be 
studied for in vivo analysis with the aim of developing implanted biosensors.  
To study the behaviour of nanomaterials in an enzyme-free medium, we synthesized 
Palladium-Cadmium (Pd-Cd) nanostructure. Then, we deposited the nanomaterials on a glassy 
carbon electrode. The fabricated electrode has strong and sensitive current responses to glucose. 
The sensor is capable of sensing glucose amperometrically at a very negative potential, -400 mV 
(Ag/AgCl), where the interference from the oxidation of common interfering species such as 
AA, AP, and UA is effectively avoided. In addition, the high sensitivity of the electrode in 
neutral pH (7.4) corroborates its longevity. The electrode has many other desirable properties 
including low detection limit, high sensitivity, short response time, and satisfactory linear 
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concentration range. However, its response in very low potential and its biocompatibility, life 
time and mechanical stability are three main issues that need to be investigated in the future.  
Table 9.1 summarizes the properties of the glucose sensors which were designed and 
fabricated in this research project. 
Table 9.1 Some of the important properties of the glucose sensors reported in this dissertation. 
Sensor 
Detection 
Limit (mM) 
Sensitivity 
(µA.mM-1.cm-2) 
Mechaelis Menten 
Constant (mM) 
Lifetime 
(days) 
Linear Dynamic 
Range (mM) 
Ti/NPAu/PB/GOx 0.0025 177 2.1 60 0-2.04 
Ti/Au/BP/GOx-HRP 0.01 20 4.6 > 80 0-9 
Ti/TiO2/C/GOx 0.4 15 9.5 > 70 0-18 
PdCd/GC 0.05 146 N/A 30 0-10 
Ti: Titanium; NPAu: Nanoporous gold; PB: Prussian blue; GOx: Glucose oxidase; BP: Buckypaper; 
HRP: Horseradish peroxidise; C: Carbon; PdCd: Palladium/Cadmium; GC: Glassy carbon electrode; N/A: 
Not Applicable 
 
In all works presented in this dissertation, we tested the selectivity of the biosensor toward 
common interference species in blood and finally in our last fabricated biosensor, we reported on 
tests in human serum samples and described the comparable sensitivity of the biosensor to 
conventional testing techniques, which is promising for future applications of these sensors.  
The research and development of nanosensors for the management of diabetes will remain 
an important research area in the future. Following the single-use strips, which now accurately 
monitor glucose concentrations in 300 nL samples of blood, their already small subcutaneous 
sensors will be further miniaturized, and their 5-7 day operating lives will be extended. Through 
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increasingly accurate and continuous measurement of the first and second generation of glucose 
biosensors, the diabetic user will be adequately forewarned if and when corrective action is 
needed to maintain a healthier narrower, closer to normal, glycemic range. The pain of blood 
glucose monitoring could be eliminated and the constant worry of diabetic people is now being 
eliminated through “smart tattoo”. The closed-loop pancreas would eliminate the need for the 
patient to perform these steps because it would perform similar to a natural pancreas. Continuous 
monitoring, like that achieved by the systems discussed here, is a necessary part of this long-term 
goal. To help fulfill this goal, future work should also emphasize testing these sensors in 
comparison with commercially available sensors to better demonstrate the advantages or 
disadvantages of the nanosensors. These direct comparisons would help justify the additional 
cost and effort to overcoming the manufacturing challenges associated with nanosensors 
compared with standard sensors. The cost and effort of the large-scale manufacture of new 
sensor approaches must provide either extreme improvements in accuracy with minimal 
additional new cost or an improvement in patient quality of life. This is a large problem to 
overcome for the approaches that incorporate nanomaterials into electrochemical detection 
approaches or detect glucose through direct oxidation, because the patient must still undergo the 
same sampling methods (ﬁnger-stick), yielding no improvement in quality of life. To have an 
impact on diabetes, these sensors must demonstrate extremely high improvements in response 
because cost is unlikely to decrease below current manufacturing approaches.  
Success in this direction demands a detailed understanding of the underlying biochemistry, 
physiology, surface chemistry, electrochemistry, and material chemistry. As this field enters its 
sixth decade of intense research, we expect significant efforts that couple the fundamental 
sciences with technological advances. This stretching of the ingenuity of researchers will result 
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in advances including the use of nanomaterials for improved electrical contact between the redox 
center of GOx and electrode supports, enhanced “genetically engineered” GOx, new “painless” 
in-vitro testing, artificial (biomimetic) receptors for glucose, advanced biocompatible membrane 
materials, the coupling of minimally invasive monitoring with compact insulin delivery system, 
new innovative approaches for noninvasive monitoring, and miniaturized long-term implants.  
Finally, from all our works in the area of enzyme-analyte-nanomaterials interactions, we 
believe that surface morphology may also play an important role in other interfacial 
biomolecular probe-target interaction, such as nucleic acid hybridization and antigen-antibody 
interactions. Therefore, the observations reported in this dissertation may guide the development 
of both sensors and materials with great capabilities to improve the lives of patients living with 
diabetes, cancer and other diseases through progress in electrochemistry and biotechnology. 
